HCPCS J codes: Drugs administered other than oral method
1112 active HCPCS Level II codes beginning with J, from the CMS October 2026 quarterly file. "Added" is the year the code first appeared in the HCPCS file.
| Code | Long description | Short description | Added |
|---|---|---|---|
J0013 | Esketamine, nasal spray, 1 mg | Esketamine, nasal spray | 2026 |
J0014 | Cocaine hydrochloride nasal solution (goprelto), 1 mg | Cocaine hcl nasal (goprelto) | 2026 |
J0120 | Injection, tetracycline, up to 250 mg | Tetracyclin injection | 1986 |
J0121 | Injection, omadacycline, 1 mg | Inj., omadacycline, 1 mg | 2019 |
J0122 | Injection, eravacycline, 1 mg | Inj., eravacycline, 1 mg | 2019 |
J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Abatacept injection | 2007 |
J0130 | Injection abciximab, 10 mg | Abciximab injection | 1999 |
J0131 | Injection, acetaminophen, not otherwise specified,10 mg | Inj, acetaminophen (nos) | 2012 |
J0132 | Injection, acetylcysteine, 100 mg | Acetylcysteine injection | 2006 |
J0133 | Injection, acyclovir, 5 mg | Acyclovir injection | 2006 |
J0134 | Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg | Inj acetaminophen -fresenius | 2023 |
J0136 | Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg | Inj, acetaminophen (b braun) | 2023 |
J0137 | Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg | Inj, acetaminophen (hikma) | 2023 |
J0138 | Injection, acetaminophen 10 mg and ibuprofen 3 mg | Inj acetaminoph 10mg/ibu 3mg | 2024 |
J0139 | Injection, adalimumab, 1 mg | Inj, adalimumab, 1 mg | 2025 |
J0153 | Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | Adenosine inj 1mg | 2015 |
J0162 | Injection, epinephrine (fresenius), not therapeutically equivalent to j0165, 0.1 mg | Inj epinephrine (fresenius) | 2026 |
J0163 | Injection, epinephrine in sodium chloride (endo), 0.1 mg | Epinephrine in nacl (endo) | 2025 |
J0164 | Injection, epinephrine in sodium chloride (baxter), 0.1 mg | Epinephrine in nacl (baxter) | 2025 |
J0165 | Injection, epinephrine, not otherwise specified, 0.1 mg | Inj epinephrine nos 0.1 mg | 2025 |
J0166 | Injection, epinephrine (bpi), not therapeutically equivalent to j0165, 0.1 mg | Inj epinephrine (bpi) | 2025 |
J0167 | Injection, epinephrine (hospira), not therapeutically equivalent to j0165, 0.1 mg | Inj epinephrine (hospira) | 2025 |
J0168 | Injection, epinephrine (international medication systems), not therapeutically equivalent to j0165, 0.1 mg | Epinephrine (intl med sys) | 2025 |
J0169 | Injection, epinephrine (adrenalin), not therapeutically equivalent to j0165, 0.1 mg | Inj epinephrine (adrenalin) | 2025 |
J0174 | Lecanemab-irmb, for intravenous injection, 1 mg | Lecanemab-irmb, for iv inj | 2023 |
J0175 | Injection, donanemab-azbt, 2 mg | Inj, donanemab-azbt, 2 mg | 2024 |
J0177 | Injection, aflibercept hd, 1 mg | Inj, aflibercept hd, 1 mg | 2024 |
J0178 | Injection, aflibercept, 1 mg | Aflibercept injection | 2013 |
J0179 | Injection, brolucizumab-dbll, 1 mg | Inj, brolucizumab-dbll, 1 mg | 2020 |
J0180 | Injection, agalsidase beta, 1 mg | Agalsidase beta injection | 2005 |
J0184 | Injection, amisulpride, 1 mg | Inj, amisulpride, 1 mg | 2024 |
J0185 | Injection, aprepitant, 1 mg | Inj., aprepitant, 1 mg | 2019 |
J0202 | Injection, alemtuzumab, 1 mg | Injection, alemtuzumab | 2016 |
J0206 | Injection, allopurinol sodium, 1 mg | Inj allopurinol sodium 1 mg | 2023 |
J0207 | Injection, amifostine, 500 mg | Amifostine | 1998 |
J0208 | Injection, sodium thiosulfate (pedmark), 100 mg | Inj, pedmark, 100 mg | 2023 |
J0209 | Injection, sodium thiosulfate (hope), 100 mg | Inj, sod thiosulfate (hope) | 2024 |
J0210 | Injection, methyldopate hcl, up to 250 mg | Methyldopate hcl injection | 1984 |
J0211 | Injection, sodium nitrite 3 mg and sodium thiosulfate 125 mg (nithiodote) | Inj, nithiodote, 3mg / 125mg | 2024 |
J0216 | Injection, alfentanil hydrochloride, 500 micrograms | Inj, alfentanil hcl, 500mcg | 2023 |
J0217 | Injection, velmanase alfa-tycv, 1 mg | Inj velmanase alfa-tycv 1 mg | 2024 |
J0218 | Injection, olipudase alfa-rpcp, 1 mg | Inj olipudase alfa-rpcp 1mg | 2023 |
J0219 | Injection, avalglucosidase alfa-ngpt, 4 mg | Inj aval alfa-nqpt 4mg | 2022 |
J0220 | Injection, alglucosidase alfa, 10 mg, not otherwise specified | Alglucosidase alfa injection | 2008 |
J0221 | Injection, alglucosidase alfa, (lumizyme), 10 mg | Lumizyme injection | 2012 |
J0222 | Injection, patisiran, 0.1 mg | Inj., patisiran, 0.1 mg | 2019 |
J0223 | Injection, givosiran, 0.5 mg | Inj givosiran 0.5 mg | 2020 |
J0224 | Injection, lumasiran, 0.5 mg | Inj. lumasiran, 0.5 mg | 2021 |
J0225 | Injection, vutrisiran, 1 mg | Inj, vutrisiran, 1 mg | 2023 |
J0248 | Injection, remdesivir, 1 mg | Inj, remdesivir, 1 mg | 2021 |
J0256 | Injection, alpha 1 proteinase inhibitor (human), not otherwise specified, 10 mg | Alpha 1 proteinase inhibitor | 1989 |
J0257 | Injection, alpha 1 proteinase inhibitor (human), (glassia), 10 mg | Glassia injection | 2012 |
J0270 | Injection, alprostadil, 1.25 mcg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Alprostadil for injection | 1997 |
J0275 | Alprostadil urethral suppository (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Alprostadil urethral suppos | 1999 |
J0278 | Injection, amikacin sulfate, 100 mg | Amikacin sulfate injection | 2006 |
J0280 | Injection, aminophyllin, up to 250 mg | Aminophyllin 250 mg inj | 1984 |
J0281 | Injection, aminocaproic acid, 1 gram | Inj aminocaproic acid 1 gram | 2025 |
J0282 | Injection, amiodarone hydrochloride, 30 mg | Amiodarone hcl | 2001 |
J0283 | Injection, amiodarone hydrochloride (nexterone), 30 mg | Inj, amiodarone (nexterone) | 2023 |
J0285 | Injection, amphotericin b, 50 mg | Amphotericin b | 1999 |
J0287 | Injection, amphotericin b lipid complex, 10 mg | Amphotericin b lipid complex | 2003 |
J0289 | Injection, amphotericin b liposome, 10 mg | Amphotericin b liposome inj | 2003 |
J0290 | Injection, ampicillin sodium, 500 mg | Ampicillin 500 mg inj | 1984 |
J0291 | Injection, plazomicin, 5 mg | Inj., plazomicin, 5 mg | 2019 |
J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | Ampicillin sulbactam 1.5 gm | 1995 |
J0300 | Injection, amobarbital, up to 125 mg | Amobarbital 125 mg inj | 1982 |
J0330 | Injection, succinylcholine chloride, up to 20 mg | Succinycholine chloride inj | 1986 |
J0348 | Injection, anidulafungin, 1 mg | Anidulafungin injection | 2007 |
J0349 | Injection, rezafungin, 1 mg | Inj, rezafungin, 1 mg | 2023 |
J0360 | Injection, hydralazine hcl, up to 20 mg | Hydralazine hcl injection | 1986 |
J0364 | Injection, apomorphine hydrochloride, 1 mg | Apomorphine hydrochloride | 2007 |
J0390 | Injection, chloroquine hydrochloride, up to 250 mg | Chloroquine injection | 1986 |
J0391 | Injection, artesunate, 1 mg | Inj, artesunate, 1mg | 2024 |
J0400 | Injection, aripiprazole, intramuscular, 0.25 mg | Aripiprazole injection | 2008 |
J0401 | Injection, aripiprazole (abilify maintena), 1 mg | Inj, abilify maintena, 1 mg | 2014 |
J0402 | Injection, aripiprazole (abilify asimtufii), 1 mg | Inj, abilify asimtufii, 1 mg | 2024 |
J0456 | Injection, azithromycin, 500 mg | Azithromycin | 2000 |
J0457 | Injection, aztreonam, 100 mg | Injection, aztreonam, 100 mg | 2023 |
J0458 | Injection, aztreonam/avibactam, 7.5 mg/2.5 mg (10 mg) | Aztreonam/avibactam 10 mg | 2025 |
J0461 | Injection, atropine sulfate, 0.01 mg | Atropine sulfate injection | 2010 |
J0462 | Injection, atropine sulfate, not therapeutically equivalent to j0461, 0.01 mg | Atropine sulf, nte, 0.01 mg | 2025 |
J0463 | Injection, atropine sulfate (fresenius and therapeutically equivalent), 0.01 mg | Inj atropine (fresenius te) | 2026 |
J0470 | Injection, dimercaprol, per 100 mg | Dimecaprol injection | 1982 |
J0475 | Injection, baclofen, 10 mg | Baclofen 10 mg injection | 1994 |
J0476 | Injection, baclofen, 50 mcg for intrathecal trial | Baclofen intrathecal trial | 1999 |
J0480 | Injection, basiliximab, 20 mg | Basiliximab | 2006 |
J0485 | Injection, belatacept, 1 mg | Belatacept injection | 2013 |
J0490 | Injection, belimumab, 10 mg | Belimumab injection | 2012 |
J0491 | Injection, anifrolumab-fnia, 1 mg | Inj anifrolumab-fnia 1mg | 2022 |
J0500 | Injection, dicyclomine hcl, up to 20 mg | Dicyclomine injection | 1986 |
J0515 | Injection, benztropine mesylate, per 1 mg | Inj benztropine mesylate | 1982 |
J0517 | Injection, benralizumab, 1 mg | Inj., benralizumab, 1 mg | 2019 |
J0520 | Injection, bethanechol chloride, myotonachol or urecholine, up to 5 mg | Bethanechol chloride inject | 1984 |
J0525 | Injection, cefotetan disodium, 10 mg | Inj cefotetan disodium 10 mg | 2025 |
J0528 | Injection, fosfomycin disodium, 20 mg | Inj fosfomycin disodium 20mg | 2026 |
J0558 | Injection, penicillin g benzathine and penicillin g procaine, 100,000 units | Peng benzathine/procaine inj | 2011 |
J0561 | Injection, penicillin g benzathine, 100,000 units | Penicillin g benzathine inj | 2011 |
J0565 | Injection, bezlotoxumab, 10 mg | Inj, bezlotoxumab, 10 mg | 2018 |
J0567 | Injection, cerliponase alfa, 1 mg | Inj., cerliponase alfa 1 mg | 2019 |
J0570 | Buprenorphine implant, 74.2 mg | Buprenorphine implant 74.2mg | 2017 |
J0571 | Buprenorphine, oral, 1 mg | Buprenorphine oral 1mg | 2015 |
J0572 | Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine | Bupren/nal up to 3mg bupreno | 2015 |
J0573 | Buprenorphine/naloxone, oral, greater than 3 mg, but less than or equal to 6 mg buprenorphine | Bupren/nal 3.1 to 6mg bupren | 2015 |
J0574 | Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine | Bupren/nal 6.1 to 10mg bupre | 2015 |
J0575 | Buprenorphine/naloxone, oral, greater than 10 mg buprenorphine | Bupren/nal over 10mg bupreno | 2015 |
J0577 | Injection, buprenorphine extended-release (brixadi), less than or equal to 7 days of therapy | Inj, brixadi, 7 days or less | 2024 |
J0578 | Injection, buprenorphine extended release (brixadi), greater than 7 days and up to 28 days of therapy | Inj brixadi, more than 7 day | 2024 |
J0582 | Injection, bivalirudin (endo), not therapeutically equivalent to j0583, 1 mg | Bivalirudin (endo) 1 mg | 2025 |
J0583 | Injection, bivalirudin, 1 mg | Bivalirudin | 2004 |
J0584 | Injection, burosumab-twza 1 mg | Injection, burosumab-twza 1m | 2019 |
J0585 | Injection, onabotulinumtoxina, 1 unit | Injection,onabotulinumtoxina | 1991 |
J0586 | Injection, abobotulinumtoxina, 5 units | Abobotulinumtoxina | 2010 |
J0587 | Injection, rimabotulinumtoxinb, 100 units | Inj, rimabotulinumtoxinb | 2002 |
J0588 | Injection, incobotulinumtoxin a, 1 unit | Incobotulinumtoxin a | 2012 |
J0589 | Injection, daxibotulinumtoxina-lanm, 1 unit | Inj daxibotulinumtoxina-lanm | 2024 |
J0591 | Injection, deoxycholic acid, 1 mg | Inj deoxycholic acid, 1 mg | 2020 |
J0592 | Injection, buprenorphine hydrochloride, 0.1 mg | Buprenorphine hydrochloride | 2003 |
J0593 | Injection, lanadelumab-flyo, 1 mg (code may be used for medicare when drug administered under direct supervision of a physician, not for use when drug is self-administered) | Inj., lanadelumab-flyo, 1 mg | 2019 |
J0594 | injection, busulfan, 1 mg | Busulfan injection | 2007 |
J0595 | Injection, butorphanol tartrate, 1 mg | Butorphanol tartrate 1 mg | 2004 |
J0596 | Injection, c1 esterase inhibitor (recombinant), ruconest, 10 units | Injection, ruconest | 2016 |
J0597 | Injection, c-1 esterase inhibitor (human), berinert, 10 units | C-1 esterase, berinert | 2011 |
J0598 | Injection, c-1 esterase inhibitor (human), cinryze, 10 units | C-1 esterase, cinryze | 2010 |
J0599 | Injection, c-1 esterase inhibitor (human), (haegarda), 10 units | Inj., haegarda 10 units | 2019 |
J0600 | Injection, edetate calcium disodium, up to 1000 mg | Edetate calcium disodium inj | 1982 |
J0601 | Sevelamer carbonate (renvela or therapeutically equivalent), oral, 20 mg (for esrd on dialysis) | Sevelamer carbonate 20 mg | 2025 |
J0602 | Sevelamer carbonate (renvela or therapeutically equivalent), oral, powder, 20 mg (for esrd on dialysis) | Sevelamer carbonate pdr 20mg | 2025 |
J0603 | Sevelamer hydrochloride (renagel or therapeutically equivalent), oral, 20 mg (for esrd on dialysis) | Sevelamer hydrochloride 20mg | 2025 |
J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | Cinacalcet, esrd on dialysis | 2018 |
J0605 | Sucroferric oxyhydroxide, oral, 5 mg (for esrd on dialysis) | Sucroferric oxyhydroxide 5mg | 2025 |
J0606 | Injection, etelcalcetide, 0.1 mg | Inj, etelcalcetide, 0.1 mg | 2018 |
J0607 | Lanthanum carbonate, oral, 5 mg (for esrd on dialysis) | Lanthanum carbonate oral 5mg | 2025 |
J0608 | Lanthanum carbonate, oral, powder, 5 mg, not therapeutically equivalent to j0607 (for esrd on dialysis) | Lanthanum carbonate pwdr 5mg | 2025 |
J0609 | Ferric citrate, oral, 3 mg ferric iron, (for esrd on dialysis) | Ferric citrate orl 3 mg iron | 2025 |
J0612 | Injection, calcium gluconate, not otherwise specified, 10 mg | Inj, calcium gluconate, nos | 2023 |
J0613 | Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg | Calcium glucon (wg critical) | 2023 |
J0614 | Injection, treosulfan, 50 mg | Inj, treosulfan, 50 mg | 2025 |
J0615 | Calcium acetate, oral, 23 mg (for esrd on dialysis) | Calcium acetate, oral, 23 mg | 2025 |
J0616 | Injection, metoprolol tartrate, 1 mg | Inj metoprolol tartrate 1 mg | 2025 |
J0618 | Injection, calcium chloride, 2 mg | Inj, calcium chloride, 2 mg | 2025 |
J0620 | Injection, calcium glycerophosphate and calcium lactate, per 10 ml | Calcium glycer & lact/10 ml | 1982 |
J0630 | Injection, calcitonin salmon, up to 400 units | Calcitonin salmon injection | 1982 |
J0636 | Injection, calcitriol, 0.1 mcg | Inj calcitriol per 0.1 mcg | 2003 |
J0637 | Injection, caspofungin acetate, 5 mg | Caspofungin acetate | 2003 |
J0638 | Injection, canakinumab, 1 mg | Canakinumab injection | 2011 |
J0641 | Injection, levoleucovorin, not otherwise specified, 0.5 mg | Inj levoleucovorin nos 0.5mg | 2009 |
J0642 | Injection, levoleucovorin (khapzory), 0.5 mg | Injection, khapzory, 0.5 mg | 2019 |
J0643 | Injection, leucovorin calcium, not otherwise specified, 1 mg | Inj leucovorin calcium 1 mg | 2026 |
J0644 | Injection, leucovorin calcium (avyxa), 1 mg | Inj, leucovorin cal (avyxa) | 2026 |
J0650 | Injection, levothyroxine sodium, not otherwise specified, 10 mcg | Inj, levothyroxine nos 10mcg | 2024 |
J0651 | Injection, levothyroxine sodium (fresenius kabi), not therapeutically equivalent to j0650, 10 mcg | Inj, levothyroxine, freskabi | 2024 |
J0652 | Injection, levothyroxine sodium (hikma), not therapeutically equivalent to j0650, 10 mcg | Inj, levothyroxine, hikma | 2024 |
J0654 | Injection, liothyronine, 1 mcg | Inj, liothyronine, 1 mcg | 2026 |
J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | Inj, bupivacaine, nos, 0.5mg | 2023 |
J0666 | Injection, bupivacaine liposome, 1 mg | Inj, bupivacaine liposome | 2025 |
J0668 | Instillation, bupivacaine and meloxicam, 1 mg/0.03 mg | Instill, bupivac and meloxic | 2025 |
J0670 | Injection, mepivacaine hydrochloride, per 10 ml | Inj mepivacaine hcl/10 ml | 1986 |
J0675 | Injection, carboprost tromethamine, 0.1 mg | Inj, carboprost, 0.1 mg | 2025 |
J0681 | Injection, ceftobiprole medocaril sodium, 3 mg | Inj ceftobipole medocarl 3mg | 2025 |
J0687 | Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mg | Inj cefazolin (wg crit care) | 2024 |
J0688 | Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg | Inj cefazolin sodium, hikma | 2024 |
J0689 | Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg | Inj cefazolin sodium, baxter | 2023 |
J0690 | Injection, cefazolin sodium, 500 mg | Cefazolin sodium injection | 1982 |
J0691 | Injection, lefamulin, 1 mg | Inj lefamulin 1 mg | 2020 |
J0692 | Injection, cefepime hydrochloride, 500 mg | Cefepime hcl for injection | 2002 |
J0694 | Injection, cefoxitin sodium, 1 gm | Cefoxitin sodium injection | 1992 |
J0695 | Injection, ceftolozane 50 mg and tazobactam 25 mg | Inj ceftolozane tazobactam | 2016 |
J0696 | Injection, ceftriaxone sodium, per 250 mg | Ceftriaxone sodium injection | 1990 |
J0697 | Injection, sterile cefuroxime sodium, per 750 mg | Sterile cefuroxime injection | 1990 |
J0698 | Injection, cefotaxime sodium, per gm | Cefotaxime sodium injection | 1991 |
J0699 | Injection, cefiderocol, 10 mg | Inj, cefiderocol, 10 mg | 2021 |
J0701 | Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mg | Inj. cefepime hcl (baxter) | 2023 |
J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Betamethasone acet&sod phosp | 1995 |
J0703 | Injection, cefepime hydrochloride (b braun), not therapeutically equivalent to maxipime, 500 mg | Inj, cefepime hcl (b braun) | 2023 |
J0706 | Injection, caffeine citrate, 5 mg | Caffeine citrate injection | 2002 |
J0712 | Injection, ceftaroline fosamil, 10 mg | Ceftaroline fosamil inj | 2012 |
J0713 | Injection, ceftazidime, per 500 mg | Inj ceftazidime per 500 mg | 1996 |
J0714 | Injection, ceftazidime and avibactam, 0.5 g/0.125 g | Ceftazidime and avibactam | 2016 |
J0716 | Injection, centruroides immune f(ab)2, up to 120 milligrams | Centruroides immune f(ab) | 2013 |
J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Certolizumab pegol inj 1mg | 2014 |
J0720 | Injection, chloramphenicol sodium succinate, up to 1 gm | Chloramphenicol sodium injec | 1982 |
J0725 | Injection, chorionic gonadotropin, per 1,000 usp units | Chorionic gonadotropin/1000u | 1986 |
J0735 | Injection, clonidine hydrochloride, 1 mg | Clonidine hydrochloride | 1998 |
J0736 | Injection, clindamycin phosphate, 300 mg | Inj, clindamycin phosp 300mg | 2023 |
J0737 | Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg | Inj, clindamycin (baxter) | 2023 |
J0738 | Injection, lenacapavir, 1 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv) | Hiv prep, inj, lenacapavir | 2025 |
J0739 | Injection, cabotegravir, 1mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv) | Hiv prep, inj, cabotegravir | 2022 |
J0740 | Injection, cidofovir, 375 mg | Cidofovir injection | 1998 |
J0741 | Injection, cabotegravir and rilpivirine, 2mg/3mg | Inj, cabote rilpivir 2mg 3mg | 2021 |
J0742 | Injection, imipenem 4 mg, cilastatin 4 mg and relebactam 2 mg | Inj imip 4 cilas 4 releb 2mg | 2020 |
J0743 | Injection, cilastatin sodium; imipenem, per 250 mg | Cilastatin sodium injection | 1993 |
J0744 | Injection, ciprofloxacin for intravenous infusion, 200 mg | Ciprofloxacin iv | 2002 |
J0745 | Injection, codeine phosphate, per 30 mg | Inj codeine phosphate /30 mg | 1986 |
J0750 | Emtricitabine 200mg and tenofovir disoproxil fumarate 300mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv) | Hiv prep, ftc/tdf 200/300mg | 2024 |
J0751 | Emtricitabine 200mg and tenofovir alafenamide 25mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv) | Hiv prep, ftc/taf 200/25mg | 2024 |
J0752 | Oral, lenacapavir, 300 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv) | Hiv prep, oral lenacapavir | 2025 |
J0759 | Injection, clevidipine butyrate, 1 mg | Inj, clevidipine, 1 mg | 2025 |
J0770 | Injection, colistimethate sodium, up to 150 mg | Colistimethate sodium inj | 1982 |
J0775 | Injection, collagenase, clostridium histolyticum, 0.01 mg | Collagenase, clost hist inj | 2011 |
J0780 | Injection, prochlorperazine, up to 10 mg | Prochlorperazine injection | 1984 |
J0791 | Injection, crizanlizumab-tmca, 5 mg | Inj crizanlizumab-tmca 5mg | 2020 |
J0799 | Fda approved prescription drug, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv), not otherwise classified | Hiv prep, fda approved, noc | 2024 |
J0801 | Injection, corticotropin (acthar gel), up to 40 units | Inj. acthar gel to 40 units | 2023 |
J0802 | Injection, corticotropin (ani), up to 40 units | Inj. (ani), up to 40 units | 2023 |
J0834 | Injection, cosyntropin, 0.25 mg | Inj., cosyntropin, 0.25 mg | 2010 |
J0840 | Injection, crotalidae polyvalent immune fab (ovine), up to 1 gram | Crotalidae poly immune fab | 2012 |
J0841 | Injection, crotalidae immune f(ab')2 (equine), 120 mg | Inj crotalidae im f(ab')2 eq | 2019 |
J0850 | Injection, cytomegalovirus immune globulin intravenous (human), per vial | Cytomegalovirus imm iv /vial | 1982 |
J0870 | Injection, imetelstat, 1 mg | Injection, imetelstat, 1 mg | 2025 |
J0871 | Injection, daptomycin (endo), not therapeutically equivalent to j0878, 1 mg | Inj, daptomycin (endo) 1mg | 2026 |
J0872 | Injection, daptomycin (xellia), unrefrigerated, not therapeutically equivalent to j0878 or j0873, 1 mg | Daptomycin (xellia) unrefrig | 2024 |
J0873 | Injection, daptomycin (xellia), not therapeutically equivalent to j0878 or j0872, 1 mg | Inj daptomycin (xellia) | 2024 |
J0874 | Injection, daptomycin (baxter), not therapeutically equivalent to j0878, 1 mg | Inj, daptomycin (baxter) | 2023 |
J0875 | Injection, dalbavancin, 5 mg | Injection, dalbavancin | 2016 |
J0877 | Injection, daptomycin (hospira), not therapeutically equivalent to j0878, 1 mg | Inj, daptomycin (hospira) | 2023 |
J0878 | Injection, daptomycin, 1 mg | Daptomycin injection | 2005 |
J0879 | Injection, difelikefalin, 0.1 microgram, (for esrd on dialysis) | Difelikefalin, esrd on dialy | 2022 |
J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Darbepoetin alfa, non-esrd | 2006 |
J0882 | Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis) | Darbepoetin alfa, esrd use | 2006 |
J0883 | Injection, argatroban, 1 mg (for non-esrd use) | Argatroban nonesrd use 1mg | 2017 |
J0884 | Injection, argatroban, 1 mg (for esrd on dialysis) | Argatroban esrd dialysis 1mg | 2017 |
J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | Epoetin alfa, non-esrd | 2006 |
J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | Epoetin beta esrd use | 2015 |
J0888 | Injection, epoetin beta, 1 microgram, (for non esrd use) | Epoetin beta non esrd | 2015 |
J0890 | Injection, peginesatide, 0.1 mg (for esrd on dialysis) | Peginesatide injection | 2013 |
J0891 | Injection, argatroban (accord), not therapeutically equivalent to j0883, 1 mg (for non-esrd use) | Argatroban nonesrd (accord) | 2023 |
J0892 | Injection, argatroban (accord), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis) | Argatroban dialysis (accord) | 2023 |
J0893 | Injection, decitabine (sun pharma), not therapeutically equivalent to j0894, 1 mg | Inj, decitabine (sun pharma) | 2023 |
J0894 | Injection, decitabine, 1 mg | Decitabine injection | 2007 |
J0895 | Injection, deferoxamine mesylate, 500 mg | Deferoxamine mesylate inj | 1992 |
J0896 | Injection, luspatercept-aamt, 0.25 mg | Inj luspatercept-aamt 0.25mg | 2020 |
J0897 | Injection, denosumab, 1 mg | Denosumab injection | 2012 |
J0898 | Injection, argatroban (auromedics), not therapeutically equivalent to j0883, 1 mg (for non-esrd use) | Argatroban nonesrd (auromed) | 2023 |
J0899 | Injection, argatroban (auromedics), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis) | Argatroban dialysis, auromed | 2023 |
J0901 | Vadadustat, oral, 1 mg (for esrd on dialysis) | Vadadustat oral 1mg for esrd | 2025 |
J0911 | Instillation, taurolidine 1.35 mg and heparin sodium 100 units (central venous catheter lock for adult patients receiving chronic hemodialysis) | Inst tauro 1.35mg/hep 100u | 2024 |
J0945 | Injection, brompheniramine maleate, per 10 mg | Brompheniramine maleate inj | 1982 |
J1000 | Injection, depo-estradiol cypionate, up to 5 mg | Depo-estradiol cypionate inj | 1982 |
J1010 | Injection, methylprednisolone acetate, 1 mg | Inj, methylpred acetate 1 mg | 2024 |
J1050 | Injection, medroxyprogesterone acetate, 1 mg | Medroxyprogesterone acetate | 2013 |
J1071 | Injection, testosterone cypionate, 1 mg | Inj testosterone cypionate | 2015 |
J1072 | Injection, testosterone cypionate (azmiro), 1 mg | Inj, testosterone, azmiro | 2025 |
J1073 | Testosterone pellet, implant, 75 mg | Testosterone pellet 75 mg | 2026 |
J1095 | Injection, dexamethasone 9 percent, intraocular, 1 microgram | Injection, dexamethasone 9% | 2019 |
J1096 | Dexamethasone, lacrimal ophthalmic insert, 0.1 mg | Dexametha opth insert 0.1 mg | 2019 |
J1097 | Phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml | Phenylep ketorolac opth soln | 2019 |
J1098 | Articaine ophthalmic, 8% solution, 0.4 ml | Articaine ophthalmi 8% 0.4ml | 2026 |
J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Dexamethasone sodium phos | 1982 |
J1105 | Dexmedetomidine, oral, 1 mcg | Dexmedetomidine film, 1 mcg | 2024 |
J1110 | Injection, dihydroergotamine mesylate, per 1 mg | Inj dihydroergotamine mesylt | 1982 |
J1120 | Injection, acetazolamide sodium, up to 500 mg | Acetazolamid sodium injectio | 1982 |
J1130 | Injection, diclofenac sodium, 0.5 mg | Inj diclofenac sodium 0.5mg | 2017 |
J1160 | Injection, digoxin, up to 0.5 mg | Digoxin injection | 1982 |
J1162 | Injection, digoxin immune fab (ovine), per vial | Digoxin immune fab (ovine) | 2006 |
J1163 | Injection, diltiazem hydrochloride, 0.5 mg | Inj, diltiazem hcl, 0.5 mg | 2025 |
J1164 | Injection, diltiazem hydrochloride in 0.72% sodium chloride, 0.5 mg | Inj diltiazem in 0.72% nacl | 2026 |
J1165 | Injection, phenytoin sodium, per 50 mg | Phenytoin sodium injection | 1982 |
J1171 | Injection, hydromorphone, 0.1 mg | Inj, hydromorphone, 0.1 mg | 2024 |
J1180 | Injection, dyphylline, up to 500 mg | Dyphylline injection | 1982 |
J1190 | Injection, dexrazoxane hydrochloride, per 250 mg | Dexrazoxane hcl injection | 1997 |
J1200 | Injection, diphenhydramine hcl, up to 50 mg | Diphenhydramine hcl injectio | 1982 |
J1201 | Injection, cetirizine hydrochloride, 0.5 mg | Inj. cetirizine hcl 0.5mg | 2020 |
J1202 | Miglustat, oral, 65 mg | Miglustat oral 65 mg | 2024 |
J1203 | Injection, cipaglucosidase alfa-atga, 5 mg | Inj, cipaglucosidase, 5 mg | 2024 |
J1205 | Injection, chlorothiazide sodium, per 500 mg | Chlorothiazide sodium inj | 1982 |
J1212 | Injection, dmso, dimethyl sulfoxide, 50%, 50 ml | Dimethyl sulfoxide 50% 50 ml | 1986 |
J1230 | Injection, methadone hcl, up to 10 mg | Methadone injection | 1982 |
J1240 | Injection, dimenhydrinate, up to 50 mg | Dimenhydrinate injection | 1984 |
J1245 | Injection, dipyridamole, per 10 mg | Dipyridamole injection | 1993 |
J1250 | Injection, dobutamine hydrochloride, per 250 mg | Inj dobutamine hcl/250 mg | 1996 |
J1260 | Injection, dolasetron mesylate, 10 mg | Dolasetron mesylate | 1999 |
J1265 | Injection, dopamine hcl, 40 mg | Dopamine injection | 2006 |
J1270 | Injection, doxercalciferol, 1 mcg | Injection, doxercalciferol | 2002 |
J1271 | Injection, doxycycline hyclate, 1 mg | Inj doxycycline hyclate 1 mg | 2025 |
J1289 | Injection, narsoplimab-wuug, 1 mg | Narsoplimab-wuug, 1 mg | 2026 |
J1290 | Injection, ecallantide, 1 mg | Ecallantide injection | 2011 |
J1299 | Injection, eculizumab, 2 mg | Inj, eculizumab, 2 mg | 2025 |
J1301 | Injection, edaravone, 1 mg | Injection, edaravone, 1 mg | 2019 |
J1302 | Injection, sutimlimab-jome, 10 mg | Inj, sutimlimab-jome, 10 mg | 2022 |
J1303 | Injection, ravulizumab-cwvz, 10 mg | Inj., ravulizumab-cwvz 10 mg | 2019 |
J1304 | Injection, tofersen, 1 mg | Inj tofersen intrathec 1 mg | 2024 |
J1305 | Injection, evinacumab-dgnb, 5mg | Inj, evinacumab-dgnb, 5mg | 2021 |
J1306 | Injection, inclisiran, 1 mg | Injection, inclisiran, 1 mg | 2022 |
J1307 | Injection, crovalimab-akkz, 10 mg | Inj, crovalimab-akkz, 10 mg | 2025 |
J1308 | Injection, famotidine, 0.25 mg | Inj, famotidine, 0.25 mg | 2025 |
J1320 | Injection, amitriptyline hcl, up to 20 mg | Amitriptyline injection | 1982 |
J1322 | Injection, elosulfase alfa, 1 mg | Elosulfase alfa, injection | 2015 |
J1323 | Injection, elranatamab-bcmm, 1 mg | Inj, elranatamab-bcmm, 1 mg | 2024 |
J1324 | Injection, enfuvirtide, 1 mg | Enfuvirtide injection | 2007 |
J1325 | Injection, epoprostenol, 0.5 mg | Epoprostenol injection | 1998 |
J1326 | Injection, zolbetuximab-clzb, 2 mg | Inj, zolbetuximab-clzb, 2 mg | 2025 |
J1327 | Injection, eptifibatide, 5 mg | Eptifibatide injection | 2000 |
J1335 | Injection, ertapenem sodium, 500 mg | Ertapenem injection | 2004 |
J1364 | Injection, erythromycin lactobionate, per 500 mg | Erythro lactobionate /500 mg | 1995 |
J1370 | Injection, esomeprazole sodium, 1 mg | Inj, esomeprazole sod, 1 mg | 2025 |
J1380 | Injection, estradiol valerate, up to 10 mg | Estradiol valerate 10 mg inj | 1982 |
J1410 | Injection, estrogen conjugated, per 25 mg | Inj estrogen conjugate 25 mg | 1982 |
J1411 | Injection, etranacogene dezaparvovec-drlb, per therapeutic dose | Inj, hemgenix, per tx dose | 2023 |
J1412 | Injection, valoctocogene roxaparvovec-rvox, per ml, containing nominal 2 x 10^13 vector genomes | Inj roctavian ml 2x10^13vc g | 2024 |
J1413 | Injection, delandistrogene moxeparvovec-rokl, per therapeutic dose | Inj delandistrogene mox rokl | 2024 |
J1414 | Injection, fidanacogene elaparvovec-dzkt, per therapeutic dose | Inj, beqvez, per tx dose | 2025 |
J1426 | Injection, casimersen, 10 mg | Injection, casimersen, 10 mg | 2021 |
J1427 | Injection, viltolarsen, 10 mg | Inj. viltolarsen | 2021 |
J1428 | Injection, eteplirsen, 10 mg | Inj, eteplirsen, 10 mg | 2018 |
J1429 | Injection, golodirsen, 10 mg | Inj golodirsen 10 mg | 2020 |
J1430 | Injection, ethanolamine oleate, 100 mg | Ethanolamine oleate 100 mg | 2006 |
J1434 | Injection, fosaprepitant (focinvez), 1 mg | Inj, focinvez, 1mg | 2024 |
J1435 | Injection, estrone, per 1 mg | Injection estrone per 1 mg | 1982 |
J1436 | Injection, etidronate disodium, per 300 mg | Etidronate disodium inj | 1990 |
J1437 | Injection, ferric derisomaltose, 10 mg | Inj. fe derisomaltose 10 mg | 2020 |
J1438 | Injection, etanercept, 25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Etanercept injection | 2000 |
J1439 | Injection, ferric carboxymaltose, 1 mg | Inj ferric carboxymaltos 1mg | 2015 |
J1440 | Fecal microbiota, live - jslm, 1 ml | Fecal microbiota jslm 1 ml | 2023 |
J1442 | Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram | Inj filgrastim excl biosimil | 2014 |
J1447 | Injection, tbo-filgrastim, 1 microgram | Inj tbo filgrastim 1 microg | 2016 |
J1448 | Injection, trilaciclib, 1mg | Injection, trilaciclib, 1mg | 2021 |
J1449 | Injection, eflapegrastim-xnst, 0.1 mg | Inj eflapegrastim-xnst 0.1mg | 2023 |
J1450 | Injection fluconazole, 200 mg | Fluconazole | 2000 |
J1451 | Injection, fomepizole, 15 mg | Fomepizole, 15 mg | 2006 |
J1453 | Injection, fosaprepitant, 1 mg | Fosaprepitant injection | 2009 |
J1454 | Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | Inj fosnetupitant, palonoset | 2019 |
J1455 | Injection, foscarnet sodium, per 1000 mg | Foscarnet sodium injection | 1993 |
J1456 | Injection, fosaprepitant (teva), not therapeutically equivalent to j1453, 1 mg | Inj, fosaprepitant (teva) | 2023 |
J1458 | Injection, galsulfase, 1 mg | Galsulfase injection | 2007 |
J1459 | Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg | Inj ivig privigen 500 mg | 2009 |
J1460 | Injection, gamma globulin, intramuscular, 1 cc | Gamma globulin 1 cc inj | 1984 |
J1551 | Injection, immune globulin (cutaquig), 100 mg | Inj cutaquig 100 mg | 2022 |
J1552 | Injection, immune globulin (alyglo), 500 mg | Inj, alyglo, 500 mg | 2025 |
J1553 | Injection, immune globulin (yimmugo), 100 mg | Inj yimmugo 100 mg | 2026 |
J1554 | Injection, immune globulin (asceniv), 500 mg | Inj. asceniv | 2021 |
J1555 | Injection, immune globulin (cuvitru), 100 mg | Inj cuvitru, 100 mg | 2018 |
J1556 | Injection, immune globulin (bivigam), 500 mg | Inj, imm glob bivigam, 500mg | 2014 |
J1557 | Injection, immune globulin, (gammaplex), intravenous, non-lyophilized (e.g., liquid), 500 mg | Gammaplex injection | 2012 |
J1558 | Injection, immune globulin (xembify), 100 mg | Inj. xembify, 100 mg | 2020 |
J1559 | Injection, immune globulin (hizentra), 100 mg | Hizentra injection | 2011 |
J1560 | Injection, gamma globulin, intramuscular, over 10 cc | Gamma globulin > 10 cc inj | 1984 |
J1561 | Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | Gamunex-c/gammaked | 2008 |
J1566 | Injection, immune globulin, intravenous, lyophilized (e.g., powder), not otherwise specified, 500 mg | Immune globulin, powder | 2006 |
J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Octagam injection | 2008 |
J1569 | Injection, immune globulin, (gammagard liquid/gammagard liquid erc), 500 mg | Gammagard liquid/erc inj | 2008 |
J1570 | Injection, ganciclovir sodium, 500 mg | Ganciclovir sodium injection | 1994 |
J1571 | Injection, hepatitis b immune globulin (hepagam b), intramuscular, 0.5 ml | Hepagam b im injection | 2008 |
J1572 | Injection, immune globulin, (flebogamma/flebogamma dif), intravenous, non-lyophilized (e.g., liquid), 500 mg | Flebogamma injection | 2008 |
J1573 | Injection, hepatitis b immune globulin (hepagam b), intravenous, 0.5 ml | Hepagam b intravenous, inj | 2008 |
J1574 | Injection, ganciclovir sodium (exela), not therapeutically equivalent to j1570, 500 mg | Inj, ganciclovir (exela) | 2023 |
J1575 | Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin | Hyqvia 100mg immuneglobulin | 2016 |
J1576 | Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mg | Inj, panzyga, 500 mg | 2023 |
J1577 | Injection, immune globulin (qivigy), 100 mg | Inj, qivigy, 100mg | 2026 |
J1580 | Injection, garamycin, gentamicin, up to 80 mg | Garamycin gentamicin inj | 1984 |
J1595 | Injection, glatiramer acetate, 20 mg | Injection glatiramer acetate | 2004 |
J1596 | Injection, glycopyrrolate, 0.1 mg | Inj, glycopyrrolate, 0.1 mg | 2024 |
J1597 | Injection, glycopyrrolate (glyrx-pf), 0.1 mg | Inj glycopyrrolate, glyrx-pf | 2024 |
J1598 | Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg | Inj glycopyrrolate fres kabi | 2024 |
J1599 | Injection, immune globulin, intravenous, non-lyophilized (e.g., liquid), not otherwise specified, 500 mg | Ivig non-lyophilized, nos | 2011 |
J1600 | Injection, gold sodium thiomalate, up to 50 mg | Gold sodium thiomaleate inj | 1982 |
J1602 | Injection, golimumab, 1 mg, for intravenous use | Golimumab for iv use 1mg | 2014 |
J1610 | Injection, glucagon hydrochloride, per 1 mg | Glucagon hydrochloride/1 mg | 1986 |
J1611 | Injection, glucagon hydrochloride (fresenius kabi), not therapeutically equivalent to j1610, per 1 mg | Inj glucagon hcl, fresenius | 2023 |
J1612 | Injection, glucagon (gvoke), 0.01 mg | Inj glucagon (gvoke) 0.01 mg | 2025 |
J1626 | Injection, granisetron hydrochloride, 100 mcg | Granisetron hcl injection | 1998 |
J1627 | Injection, granisetron, extended-release, 0.1 mg | Inj, granisetron, xr, 0.1 mg | 2018 |
J1628 | Injection, guselkumab, 1 mg | Inj., guselkumab, 1 mg | 2019 |
J1630 | Injection, haloperidol, up to 5 mg | Haloperidol injection | 1986 |
J1631 | Injection, haloperidol decanoate, per 50 mg | Haloperidol decanoate inj | 1989 |
J1632 | Injection, brexanolone, 1 mg | Inj., brexanolone, 1 mg | 2020 |
J1640 | Injection, hemin, 1 mg | Hemin, 1 mg | 2006 |
J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | Inj heparin sodium per 10 u | 1995 |
J1643 | Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units | Inj heparin, pfizer, 1000u | 2023 |
J1644 | Injection, heparin sodium, per 1000 units | Inj heparin sodium per 1000u | 1995 |
J1645 | Injection, dalteparin sodium, per 2500 iu | Dalteparin sodium | 1997 |
J1650 | Injection, enoxaparin sodium, 10 mg | Inj enoxaparin sodium | 1996 |
J1652 | Injection, fondaparinux sodium, 0.5 mg | Fondaparinux sodium | 2003 |
J1670 | Injection, tetanus immune globulin, human, up to 250 units | Tetanus immune globulin inj | 1986 |
J1675 | Injection, histrelin acetate, 10 micrograms | Histrelin acetate | 2006 |
J1700 | Injection, hydrocortisone acetate, up to 25 mg | Hydrocortisone acetate inj | 1982 |
J1720 | Injection, hydrocortisone sodium succinate, up to 100 mg | Hydrocortisone sodium succ i | 1982 |
J1726 | Injection, hydroxyprogesterone caproate, (makena), 10 mg | Makena, 10 mg | 2018 |
J1729 | Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg | Inj hydroxyprogst capoat nos | 2018 |
J1730 | Injection, diazoxide, up to 300 mg | Diazoxide injection | 1982 |
J1736 | Injection, meloxicam (delova), 1 mg | Inj meloxicam (delova) 1mg | 2026 |
J1737 | Injection, meloxicam (azurity), 1 mg | Inj meloxicam (azurity) 1mg | 2026 |
J1738 | Injection, meloxicam, 1 mg | Inj. meloxicam 1 mg | 2020 |
J1740 | Injection, ibandronate sodium, 1 mg | Ibandronate sodium injection | 2007 |
J1741 | Injection, ibuprofen, 100 mg | Ibuprofen injection | 2013 |
J1742 | Injection, ibutilide fumarate, 1 mg | Ibutilide fumarate injection | 1998 |
J1743 | Injection, idursulfase, 1 mg | Idursulfase injection | 2008 |
J1744 | Injection, icatibant, 1 mg | Icatibant injection | 2013 |
J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Infliximab not biosimil 10mg | 2000 |
J1746 | Injection, ibalizumab-uiyk, 10 mg | Inj., ibalizumab-uiyk, 10 mg | 2019 |
J1747 | Injection, spesolimab-sbzo, 1 mg | Inj, spesolimab-sbzo, 1 mg | 2023 |
J1748 | Injection, infliximab-dyyb (zymfentra), 10 mg | Inj, zymfentra, 10 mg | 2024 |
J1749 | Injection, iloprost, 0.1 mcg | Inj, iloprost, 0.1 mcg | 2024 |
J1750 | Injection, iron dextran, 50 mg | Inj iron dextran | 2005 |
J1756 | Injection, iron sucrose, 1 mg | Iron sucrose injection | 2003 |
J1757 | Injection, tividenofusp alfa-eknm, 1 mg | Inj tivideno alfa-eknm 1 | 2026 |
J1786 | Injection, imiglucerase, 10 units | Imuglucerase injection | 2011 |
J1790 | Injection, droperidol, up to 5 mg | Droperidol injection | 1982 |
J1800 | Injection, propranolol hcl, up to 1 mg | Propranolol injection | 1982 |
J1805 | Injection, esmolol hydrochloride, 10 mg | Inj, esmolol hcl, 10mg | 2023 |
J1806 | Injection, esmolol hydrochloride (wg critical care), not therapeutically equivalent to j1805, 10 mg | Inj esmolol hcl wg crit care | 2023 |
J1807 | Injection, ethacrynate sodium, 1 mg | Inj, ethacrynate sod, 1 mg | 2025 |
J1808 | Injection, folic acid, 0.1 mg | Inj, folic acid, 0.1 mg | 2025 |
J1809 | Injection, fosdenopterin, 0.1 mg | Inj, fosdenopterin, 0.1mg | 2025 |
J1811 | Insulin (fiasp) for administration through dme (i.e., insulin pump) per 50 units | Fiasp for insulin pump use | 2023 |
J1812 | Insulin (fiasp), per 5 units | Inj. insulin (fiasp) | 2023 |
J1813 | Insulin (lyumjev) for administration through dme (i.e., insulin pump) per 50 units | Lyumjev for insulin pump use | 2023 |
J1814 | Insulin (lyumjev), per 5 units | Inj. insulin (lyumjev) | 2023 |
J1815 | Injection, insulin, per 5 units | Insulin injection | 2003 |
J1817 | Insulin for administration through dme (i.e., insulin pump) per 50 units | Insulin for insulin pump use | 2003 |
J1818 | Injection, pegzilarginase-nbln, 0.05 mg | Inj pegzilarginase-nbln | 2026 |
J1823 | Injection, inebilizumab-cdon, 1 mg | Inj. inebilizumab-cdon, 1 mg | 2021 |
J1826 | Injection, interferon beta-1a, 30 mcg | Interferon beta-1a inj | 2011 |
J1830 | Injection, interferon beta-1b, 0.25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Interferon beta-1b / .25 mg | 1982 |
J1833 | Injection, isavuconazonium, 1 mg | Injection, isavuconazonium | 2016 |
J1834 | Injection, isoniazid, 1 mg | Inj, isoniazid, 1 mg | 2025 |
J1835 | Injection, itraconazole, 50 mg | Itraconazole injection | 2002 |
J1836 | Injection, metronidazole, 10 mg | Inj, metronidazole, 10 mg | 2023 |
J1837 | Injection, posaconazole, 1 mg | Inj, posaconazole, 1 mg | 2026 |
J1885 | Injection, ketorolac tromethamine, per 15 mg | Ketorolac tromethamine inj | 1993 |
J1920 | Injection, labetalol hydrochloride, 5 mg | Inj, labetalol hcl, 5mg | 2023 |
J1921 | Injection, labetalol hydrochloride (hikma), not therapeutically equivalent to j1920, 5 mg | Inj labetalol hcl hikma, 5mg | 2023 |
J1930 | Injection, lanreotide, 1 mg | Lanreotide injection | 2009 |
J1931 | Injection, laronidase, 0.1 mg | Laronidase injection | 2005 |
J1932 | Injection, lanreotide, (cipla), 1 mg | Inj, lanreotide, (cipla) 1mg | 2022 |
J1938 | Injection, furosemide, 1 mg | Inj, furosemide, 1 mg | 2025 |
J1939 | Injection, bumetanide, 0.5 mg | Inj, bumetanide, 0.5 mg | 2024 |
J1943 | Injection, aripiprazole lauroxil, (aristada initio), 1 mg | Inj., aristada initio, 1 mg | 2019 |
J1944 | Injection, aripiprazole lauroxil, (aristada), 1 mg | Aripiprazole lauroxil 1 mg | 2019 |
J1946 | Injection, furosemide (lasix onyu), 1 mg | Inj, furose lasix onyu, 1 mg | 2026 |
J1947 | Injection, furosemide (furoscix), 1 mg | Inj, furoscix, 1 mg | 2026 |
J1950 | Injection, leuprolide acetate (for depot suspension), per 3.75 mg | Leuprolide acetate /3.75 mg | 1986 |
J1951 | Injection, leuprolide acetate for depot suspension (fensolvi), 0.25 mg | Inj fensolvi 0.25 mg | 2021 |
J1952 | Leuprolide injectable, camcevi, 1 mg | Leuprolide inj, camcevi, 1mg | 2022 |
J1954 | Injection, leuprolide acetate for depot suspension (lutrate depot), 7.5 mg | Inj leu acet lutr dpt 7.5 mg | 2023 |
J1955 | Injection, levocarnitine, per 1 gm | Inj levocarnitine per 1 gm | 1996 |
J1956 | Injection, levofloxacin, 250 mg | Levofloxacin injection | 1999 |
J1957 | Injection, levetiracetam, 5 mg | Injection levetiracetam 5 mg | 2026 |
J1958 | Injection, levetiracetam in sodium chloride, 5 mg | Inj levetirac sodi chlo 5 mg | 2026 |
J1960 | Injection, levorphanol tartrate, up to 2 mg | Levorphanol tartrate inj | 1982 |
J1961 | Injection, lenacapavir (only for use as hiv treatment), 1 mg | Inj lenacapavir (hiv tx) 1mg | 2023 |
J1980 | Injection, hyoscyamine sulfate, up to 0.25 mg | Hyoscyamine sulfate inj | 1982 |
J1990 | Injection, chlordiazepoxide hcl, up to 100 mg | Chlordiazepoxide injection | 1982 |
J2002 | Injection, lidocaine hcl in 5% dextrose, 1 mg | Inj, lidocaine in d5w, 1 mg | 2024 |
J2003 | Injection, lidocaine hydrochloride, 1 mg | Inj, lidocaine hcl, 1 mg | 2024 |
J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | Inj, lidocaine w epinephrine | 2024 |
J2010 | Injection, lincomycin hcl, up to 300 mg | Lincomycin injection | 1982 |
J2020 | Injection, linezolid, 200 mg | Linezolid injection | 2002 |
J2021 | Injection, linezolid (hospira), not therapeutically equivalent to j2020, 200 mg | Inj, linezolid (hospira) | 2023 |
J2060 | Injection, lorazepam, 2 mg | Lorazepam injection | 1982 |
J2062 | Loxapine for inhalation, 1 mg | Loxapine for inhalation 1 mg | 2019 |
J2151 | Injection, mannitol, 250 mg | Inj, mannitol, 250 mg | 2025 |
J2170 | Injection, mecasermin, 1 mg | Mecasermin injection | 2007 |
J2175 | Injection, meperidine hydrochloride, per 100 mg | Meperidine hydrochl /100 mg | 1986 |
J2180 | Injection, meperidine and promethazine hcl, up to 50 mg | Meperidine/promethazine inj | 1982 |
J2182 | Injection, mepolizumab, 1 mg | Injection, mepolizumab, 1mg | 2017 |
J2183 | Injection, meropenem (wg critical care), not therapeutically equivalent to j2185, 100 mg | Inj meropenem (wg crit care) | 2024 |
J2184 | Injection, meropenem (b. braun), not therapeutically equivalent to j2185, 100 mg | Inj, meropenem (b. braun) | 2023 |
J2185 | Injection, meropenem, 100 mg | Meropenem | 2004 |
J2186 | Injection, meropenem and vaborbactam, 10mg/10mg (20mg) | Inj., meropenem, vaborbactam | 2019 |
J2210 | Injection, methylergonovine maleate, up to 0.2 mg | Methylergonovin maleate inj | 1982 |
J2212 | Injection, methylnaltrexone, 0.1 mg | Methylnaltrexone injection | 2013 |
J2246 | Injection, micafungin in sodium (baxter), not therapeutically equivalent to j2248, 1 mg | Inj, micafungin (baxter) | 2024 |
J2247 | Injection, micafungin sodium (par pharm) not thereapeutically equivalent to j2248, 1 mg | Inj, micafungin (par pharm) | 2023 |
J2248 | Injection, micafungin sodium, 1 mg | Micafungin sodium injection | 2007 |
J2249 | Injection, remimazolam, 1 mg | Inj, remimazolam, 1 mg | 2023 |
J2250 | Injection, midazolam hydrochloride, per 1 mg | Inj midazolam hydrochloride | 1996 |
J2251 | Injection, midazolam in 0.9% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg | Inj midazolam in 0.9% nacl | 2023 |
J2252 | Injection, midazolam in 0.8% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg | Inj midazolam in 0.8% nacl | 2024 |
J2253 | Injection, midazolam (seizalam), 1 mg | Inj midazolam (seizalam) | 2024 |
J2260 | Injection, milrinone lactate, 5 mg | Inj milrinone lactate / 5 mg | 1986 |
J2265 | Injection, minocycline hydrochloride, 1 mg | Minocycline hydrochloride | 2012 |
J2267 | Injection, mirikizumab-mrkz, 1 mg | Inj, mirikizumab-mrkz, 1 mg | 2024 |
J2270 | Injection, morphine sulfate, up to 10 mg | Morphine sulfate injection | 1982 |
J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | Inj, morphine (fresenius) | 2023 |
J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | Inj morphine pf epid ithc | 2015 |
J2277 | Injection, motixafortide, 0.25 mg | Inj, motixafortide, 0.25 mg | 2024 |
J2278 | Injection, ziconotide, 1 microgram | Ziconotide injection | 2006 |
J2280 | Injection, moxifloxacin, 100 mg | Inj, moxifloxacin 100 mg | 2004 |
J2281 | Injection, moxifloxacin (fresenius kabi), not therapeutically equivalent to j2280, 100 mg | Inj moxifloxacin (fres kabi) | 2023 |
J2290 | Injection, nafcillin sodium, 20 mg | Inj, nafcillin sodium, 20 mg | 2025 |
J2291 | Injection, nafcillin sodium (baxter), 20 mg | Inj, nafcillin (baxter) 20mg | 2025 |
J2300 | Injection, nalbuphine hydrochloride, per 10 mg | Inj nalbuphine hydrochloride | 1996 |
J2305 | Injection, nitroglycerin, 5 mg | Inj, nitroglycerin, 5 mg | 2023 |
J2312 | Injection, naloxone hydrochloride, not otherwise specified, 0.01 mg | Inj naloxone hcl nos, 0.01mg | 2025 |
J2313 | Injection, naloxone hydrochloride (zimhi), 0.01 mg | Inj, naloxone (zimhi) 0.01mg | 2025 |
J2315 | Injection, naltrexone, depot form, 1 mg | Naltrexone, depot form | 2007 |
J2320 | Injection, nandrolone decanoate, up to 50 mg | Nandrolone decanoate 50 mg | 1986 |
J2323 | Injection, natalizumab, 1 mg | Natalizumab injection | 2008 |
J2325 | Injection, nesiritide, 0.1 mg | Nesiritide injection | 2006 |
J2326 | Injection, nusinersen, 0.1 mg | Inj, nusinersen, 0.1mg | 2018 |
J2327 | Injection, risankizumab-rzaa, intravenous, 1 mg | Inj risankizumab-rzaa 1 mg | 2023 |
J2329 | Injection, ublituximab-xiiy, 1mg | Inj ublituximab-xiiy, 1 mg | 2023 |
J2350 | Injection, ocrelizumab, 1 mg | Injection, ocrelizumab, 1 mg | 2018 |
J2351 | Injection, ocrelizumab, 1 mg and hyaluronidase-ocsq | Inj ocrelizumab 1mg hya-ocsq | 2025 |
J2353 | Injection, octreotide, depot form for intramuscular injection, 1 mg | Octreotide injection, depot | 2004 |
J2354 | Injection, octreotide, non-depot form for subcutaneous or intravenous injection, 25 mcg | Octreotide inj, non-depot | 2004 |
J2355 | Injection, oprelvekin, 5 mg | Oprelvekin injection | 1999 |
J2356 | Injection, tezepelumab-ekko, 1 mg | Inj tezepelumab-ekko, 1mg | 2022 |
J2357 | Injection, omalizumab, 5 mg | Omalizumab injection | 2005 |
J2358 | Injection, olanzapine, long-acting, 1 mg | Olanzapine long-acting inj | 2011 |
J2359 | Injection, olanzapine, 0.5 mg | Inj. olanzapine, 0.5mg | 2023 |
J2360 | Injection, orphenadrine citrate, up to 60 mg | Orphenadrine injection | 1982 |
J2361 | Injection, depemokimab-ulaa, 1 mg | Inj depemokimab-ulaa 1 mg | 2026 |
J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | Inj phenylephrine hcl 20 mcg | 2023 |
J2372 | Injection, phenylephrine hydrochloride (biorphen), 20 micrograms | Inj, biorphen, 20 micrograms | 2023 |
J2373 | Injection, phenylephrine hydrochloride (immphentiv), 20 micrograms | Inj, immphentiv, 20 mcg | 2024 |
J2374 | Apraclonidine hydrochloride ophthalmic, 1% solution, 0.1 ml | Apraclonidine hcl opht 0.1ml | 2026 |
J2401 | Injection, chloroprocaine hydrochloride, per 1 mg | Chloroprocaine hcl injection | 2023 |
J2402 | Injection, chloroprocaine hydrochloride (clorotekal), per 1 mg | Chloroprocaine (clorotekal) | 2023 |
J2403 | Chloroprocaine hcl ophthalmic, 3% gel, 1 mg | Chloroprocaine opht gel, 1mg | 2023 |
J2404 | Injection, nicardipine, 0.1 mg | Inj, nicardipine 0.1 mg | 2024 |
J2405 | Injection, ondansetron hydrochloride, per 1 mg | Ondansetron hcl injection | 1993 |
J2406 | Injection, oritavancin (kimyrsa), 10 mg | Injection, oritavancin 10 mg | 2021 |
J2407 | Injection, oritavancin (orbactiv), 10 mg | Injection, oritavancin | 2016 |
J2410 | Injection, oxymorphone hcl, up to 1 mg | Oxymorphone hcl injection | 1982 |
J2425 | Injection, palifermin, 50 micrograms | Palifermin injection | 2006 |
J2426 | Injection, paliperidone palmitate extended release (invega sustenna), 1 mg | Inj, invega sustenna, 1 mg | 2011 |
J2427 | Injection, paliperidone palmitate extended release (invega hafyera, or invega trinza), 1 mg | Inj, invega hafyera/trinza | 2023 |
J2428 | Injection, paliperidone palmitate extended release (erzofri), 1 mg | Inj, erzofri, 1 mg | 2025 |
J2430 | Injection, pamidronate disodium, per 30 mg | Pamidronate disodium /30 mg | 1982 |
J2440 | Injection, papaverine hcl, up to 60 mg | Papaverin hcl injection | 1986 |
J2460 | Injection, oxytetracycline hcl, up to 50 mg | Oxytetracycline injection | 1982 |
J2468 | Injection, palonosetron hydrochloride (posfrea), 25 micrograms | Inj, palonosetron (posfrea) | 2024 |
J2469 | Injection, palonosetron hcl, 25 mcg | Palonosetron hcl | 2005 |
J2470 | Injection, pantoprazole sodium, 40 mg | Inj pantoprazole sodium 40mg | 2024 |
J2471 | Injection, pantoprazole (hikma), not therapeutically equivalent to j2470, 40 mg | Inj pantoprazole(hikma) 40mg | 2024 |
J2472 | Injection, pantoprazole sodium in sodium chloride (baxter), 40 mg | Inj, pantoprazole sodium chl | 2025 |
J2501 | Injection, paricalcitol, 1 mcg | Paricalcitol | 2003 |
J2502 | Injection, pasireotide long acting, 1 mg | Inj, pasireotide long acting | 2016 |
J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | Inj pegfilgrast ex bio 0.5mg | 2022 |
J2507 | Injection, pegloticase, 1 mg | Pegloticase injection | 2012 |
J2508 | Injection, pegunigalsidase alfa-iwxj, 1 mg | Pegunigalsidase alfa-iwxj | 2024 |
J2510 | Injection, penicillin g procaine, aqueous, up to 600,000 units | Penicillin g procaine inj | 1982 |
J2515 | Injection, pentobarbital sodium, per 50 mg | Pentobarbital sodium inj | 1982 |
J2516 | Injection, pentamidine isethionate, 1 mg | Inj, pentamidine isethionate | 2026 |
J2540 | Injection, penicillin g potassium, up to 600,000 units | Penicillin g potassium inj | 1982 |
J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | Piperacillin/tazobactam | 2000 |
J2545 | Pentamidine isethionate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 300 mg | Pentamidine non-comp unit | 1992 |
J2547 | Injection, peramivir, 1 mg | Injection, peramivir | 2016 |
J2550 | Injection, promethazine hcl, up to 50 mg | Promethazine hcl injection | 1982 |
J2560 | Injection, phenobarbital sodium, up to 120 mg | Phenobarbital sodium inj | 1982 |
J2561 | Injection, phenobarbital sodium (sezaby), 1 mg | Inj, sezaby, 1 mg | 2023 |
J2562 | Injection, plerixafor, 1 mg | Plerixafor injection | 2010 |
J2590 | Injection, oxytocin, up to 10 units | Oxytocin injection | 1986 |
J2596 | Injection, vasopressin (long grove), not therapeutically equivalent to j2598, 1 unit | Vasopressin (long grove) 1 u | 2026 |
J2597 | Injection, desmopressin acetate, per 1 mcg | Inj desmopressin acetate | 1996 |
J2598 | Injection, vasopressin, 1 unit | Inj, vasopressin, 1 unit | 2023 |
J2599 | Injection, vasopressin (american regent), not therapeutically equivalent to j2598, 1 unit | Inj vasopressin (am reg) 1 u | 2023 |
J2601 | Injection, vasopressin (baxter), 1 unit | Inj, vasopressin (baxter) | 2024 |
J2650 | Injection, prednisolone acetate, up to 1 ml | Prednisolone acetate inj | 1982 |
J2670 | Injection, tolazoline hcl, up to 25 mg | Totazoline hcl injection | 1986 |
J2675 | Injection, progesterone, per 50 mg | Inj progesterone per 50 mg | 1986 |
J2679 | Injection, fluphenazine hcl, 1.25 mg | Inj fluphenazine hcl 1.25 mg | 2024 |
J2680 | Injection, fluphenazine decanoate, up to 25 mg | Fluphenazine decanoate 25 mg | 1982 |
J2690 | Injection, procainamide hcl, up to 1 gm | Procainamide hcl injection | 1982 |
J2700 | Injection, oxacillin sodium, up to 250 mg | Oxacillin sodium injeciton | 1982 |
J2704 | Injection, propofol, 10 mg | Inj, propofol, 10 mg | 2015 |
J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | Neostigmine methylslfte inj | 1982 |
J2711 | Injection, neostigmine methylsulfate 0.1 mg and glycopyrrolate 0.02 mg | Inj neostigmin/glycopyrrolat | 2026 |
J2720 | Injection, protamine sulfate, per 10 mg | Inj protamine sulfate/10 mg | 1982 |
J2724 | Injection, protein c concentrate, intravenous, human, 10 iu | Protein c concentrate | 2008 |
J2725 | Injection, protirelin, per 250 mcg | Inj protirelin per 250 mcg | 1995 |
J2730 | Injection, pralidoxime chloride, up to 1 gm | Pralidoxime chloride inj | 1986 |
J2760 | Injection, phentolamine mesylate, up to 5 mg | Phentolaine mesylate inj | 1982 |
J2765 | Injection, metoclopramide hcl, up to 10 mg | Metoclopramide hcl injection | 1982 |
J2770 | Injection, quinupristin/dalfopristin, 500 mg (150/350) | Quinupristin/dalfopristin | 2001 |
J2777 | Injection, faricimab-svoa, 0.1 mg | Inj, faricimab-svoa, 0.1mg | 2022 |
J2778 | Injection, ranibizumab, 0.1 mg | Ranibizumab injection | 2008 |
J2779 | Injection, ranibizumab, via intravitreal implant (susvimo), 0.1 mg | Inj, susvimo 0.1 mg | 2022 |
J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | Inj, pegcetacoplan, 1mg | 2023 |
J2782 | Injection, avacincaptad pegol, 0.1 mg | Inj avacincaptad pegol 0.1mg | 2024 |
J2783 | Injection, rasburicase, 0.5 mg | Rasburicase | 2004 |
J2785 | Injection, regadenoson, 0.1 mg | Regadenoson injection | 2009 |
J2786 | Injection, reslizumab, 1 mg | Injection, reslizumab, 1mg | 2017 |
J2787 | Riboflavin 5'-phosphate, ophthalmic solution (photrexa viscous/photrexa), up to 3 ml | Riboflavin photrexa/viscous | 2019 |
J2788 | Injection, rho d immune globulin, human, minidose, 50 micrograms (250 i.u.) | Rho d immune globulin 50 mcg | 2003 |
J2789 | Riboflavin 5'-phosphate, ophthalmic solution (epioxahd/epioxa), up to 2 ml | Riboflavin epioxa/hd<=2ml | 2026 |
J2790 | Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) | Rho d immune globulin inj | 1986 |
J2791 | Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu | Rhophylac injection | 2008 |
J2792 | Injection, rho d immune globulin, intravenous, human, solvent detergent, 100 iu | Rho(d) immune globulin h, sd | 1999 |
J2793 | Injection, rilonacept, 1 mg | Rilonacept injection | 2010 |
J2794 | Injection, risperidone (risperdal consta), 0.5 mg | Inj risperdal consta, 0.5 mg | 2005 |
J2795 | Injection, ropivacaine hydrochloride, 1 mg | Ropivacaine hcl injection | 2001 |
J2797 | Injection, rolapitant, 0.5 mg | Inj., rolapitant, 0.5 mg | 2019 |
J2798 | Injection, risperidone, (perseris), 0.5 mg | Inj., perseris, 0.5 mg | 2019 |
J2799 | Injection, risperidone (uzedy), 1 mg | Inj, uzedy, 1 mg | 2024 |
J2800 | Injection, methocarbamol, up to 10 ml | Methocarbamol injection | 1982 |
J2801 | Injection, risperidone (rykindo), 0.5 mg | Inj, rykindo, 0.5 mg | 2024 |
J2802 | Injection, romiplostim, 1 microgram | Inj, romiplostim 1 microgram | 2025 |
J2804 | Injection, rifampin, 1 mg | Inj, rifampin, 1 mg | 2025 |
J2805 | Injection, sincalide, 5 micrograms | Sincalide injection | 2006 |
J2810 | Injection, theophylline, per 40 mg | Inj theophylline per 40 mg | 1982 |
J2820 | Injection, sargramostim (gm-csf), 50 mcg | Sargramostim injection | 1982 |
J2840 | Injection, sebelipase alfa, 1 mg | Inj sebelipase alfa 1 mg | 2017 |
J2850 | Injection, secretin, synthetic, human, 1 microgram | Inj secretin synthetic human | 2006 |
J2860 | Injection, siltuximab, 10 mg | Injection, siltuximab | 2016 |
J2865 | Injection, sulfamethoxazole 5 mg and trimethoprim 1 mg | Inj sulfameth/trim 5 mg/1 mg | 2025 |
J2916 | Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | Na ferric gluconate complex | 2003 |
J2919 | Injection, methylprednisolone sodium succinate, 5 mg | Inj, methylpred sod succ 5mg | 2024 |
J2941 | Injection, somatropin, 1 mg | Somatropin injection | 2002 |
J2950 | Injection, promazine hcl, up to 25 mg | Promazine hcl injection | 1982 |
J2993 | Injection, reteplase, 18.1 mg | Reteplase injection | 2001 |
J2997 | Injection, alteplase recombinant, 1 mg | Alteplase recombinant | 2001 |
J2998 | Injection, plasminogen, human-tvmh, 1 mg | Inj plasminogen tvmh 1mg | 2022 |
J3000 | Injection, streptomycin, up to 1 gm | Streptomycin injection | 1982 |
J3010 | Injection, fentanyl citrate, 0.1 mg | Fentanyl citrate injection | 1982 |
J3030 | Injection, sumatriptan succinate, 6 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Sumatriptan succinate / 6 mg | 1986 |
J3031 | Injection, fremanezumab-vfrm, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self-administered) | Inj., fremanezumab-vfrm 1 mg | 2019 |
J3032 | Injection, eptinezumab-jjmr, 1 mg | Inj. eptinezumab-jjmr 1 mg | 2020 |
J3055 | Injection, talquetamab-tgvs, 0.25 mg | Inj talquetamab-tgvs 0.25 mg | 2024 |
J3060 | Injection, taliglucerase alfa, 10 units | Inj, taliglucerase alfa 10 u | 2014 |
J3070 | Injection, pentazocine, 30 mg | Pentazocine injection | 1982 |
J3090 | Injection, tedizolid phosphate, 1 mg | Inj tedizolid phosphate | 2016 |
J3095 | Injection, telavancin, 10 mg | Telavancin injection | 2011 |
J3101 | Injection, tenecteplase, 1 mg | Tenecteplase injection | 2009 |
J3105 | Injection, terbutaline sulfate, up to 1 mg | Terbutaline sulfate inj | 1987 |
J3110 | Injection, teriparatide, 10 mcg | Teriparatide injection | 2005 |
J3111 | Injection, romosozumab-aqqg, 1 mg | Inj. romosozumab-aqqg 1 mg | 2019 |
J3121 | Injection, testosterone enanthate, 1 mg | Inj testostero enanthate 1mg | 2015 |
J3145 | Injection, testosterone undecanoate, 1 mg | Testosterone undecanoate 1mg | 2015 |
J3230 | Injection, chlorpromazine hcl, up to 50 mg | Chlorpromazine hcl injection | 1982 |
J3240 | Injection, thyrotropin alpha, 0.9 mg, provided in 1.1 mg vial | Thyrotropin injection | 1986 |
J3241 | Injection, teprotumumab-trbw, 10 mg | Inj. teprotumumab-trbw 10 mg | 2020 |
J3243 | Injection, tigecycline, 1 mg | Tigecycline injection | 2007 |
J3244 | Injection, tigecycline (accord), not therapeutically equivalent to j3243, 1 mg | Inj. tigecycline (accord) | 2023 |
J3245 | Injection, tildrakizumab, 1 mg | Inj., tildrakizumab, 1 mg | 2019 |
J3246 | Injection, tirofiban hcl, 0.25 mg | Tirofiban hcl | 2005 |
J3247 | Injection, secukinumab, intravenous, 1 mg | Inj secukinumab intrav 1mg | 2024 |
J3250 | Injection, trimethobenzamide hcl, up to 200 mg | Trimethobenzamide hcl inj | 1982 |
J3260 | Injection, tobramycin sulfate, up to 80 mg | Tobramycin sulfate injection | 1982 |
J3262 | Injection, tocilizumab, 1 mg | Tocilizumab injection | 2011 |
J3263 | Injection, toripalimab-tpzi, 1 mg | Inj, toripalimab-tpzi, 1 mg | 2024 |
J3265 | Injection, torsemide, 10 mg/ml | Injection torsemide 10 mg/ml | 1996 |
J3268 | Injection, delafloxacin, 1 mg | Injection, delafloxacin | 2026 |
J3285 | Injection, treprostinil, 1 mg | Treprostinil injection | 2006 |
J3290 | Injection, tranexamic acid, 5 mg | Inj, tranexamic acid 5 mg | 2025 |
J3291 | Injection, tranexamic acid in sodium chloride, 5 mg | Tranexamic acid in sod chlor | 2026 |
J3299 | Injection, triamcinolone acetonide (xipere), 1 mg | Inj xipere 1 mg | 2022 |
J3300 | Injection, triamcinolone acetonide (triesence), preservative free, 1 mg | Triamcinolone a inj prs-free | 2009 |
J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Triamcinolone acet inj nos | 1991 |
J3302 | Injection, triamcinolone diacetate, per 5 mg | Triamcinolone diacetate inj | 1991 |
J3303 | Injection, triamcinolone hexacetonide, per 5 mg | Triamcinolone hexacetonl inj | 1991 |
J3304 | Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | Inj triamcinolone ace xr 1mg | 2019 |
J3315 | Injection, triptorelin pamoate, 3.75 mg | Triptorelin pamoate | 2003 |
J3316 | Injection, triptorelin, extended-release, 3.75 mg | Inj., triptorelin xr 3.75 mg | 2019 |
J3350 | Injection, urea, up to 40 gm | Urea injection | 1986 |
J3357 | Ustekinumab, for subcutaneous injection, 1 mg | Ustekinumab sub cu inj, 1 mg | 2011 |
J3358 | Ustekinumab, for intravenous injection, 1 mg | Ustekinumab, iv inject, 1 mg | 2018 |
J3360 | Injection, diazepam, up to 5 mg | Diazepam injection | 1982 |
J3373 | Injection, vancomycin hydrochloride, 10 mg | Inj, vancomycin hcl, 10 mg | 2025 |
J3374 | Injection, vancomycin hydrochloride (mylan) not therapeutically equivalent to j3373, 10 mg | Inj, vancomycin (mylan) 10mg | 2025 |
J3375 | Injection, vancomycin hydrochloride (tyzavan), not therapeutically equivalent to j3373, 10 mg | Inj, vanco (tyzavan) 10mg | 2025 |
J3376 | Injection, vancomycin hcl (hikma), not therapeutically equivalent to j3373, 10 mg | Inj vancomycin (hikma) 10mg | 2026 |
J3379 | Injection, valproate sodium, 5 mg | Inj, valproate sod, 5 mg | 2026 |
J3380 | Injection, vedolizumab, intravenous, 1 mg | Inj vedolizumab iv 1 mg | 2016 |
J3385 | Injection, velaglucerase alfa, 100 units | Velaglucerase alfa | 2011 |
J3386 | Injection, etuvetidigene autotemcel, per treatment | Etuvetidigene autotemecel | 2026 |
J3387 | Injection, elivaldogene autotemcel, per treatment | Inj elivaldogene autotemecel | 2026 |
J3389 | Topical administration, prademagene zamikeracel, per treatment | Topi adm prad zami per treat | 2026 |
J3391 | Injection, atidarsagene autotemcel, per treatment | Inj, atidarsagene autotemcel | 2025 |
J3392 | Injection, exagamglogene autotemcel, per treatment | Inj, exagamglogene autotem | 2025 |
J3393 | Injection, betibeglogene autotemcel, per treatment | Inj, betibeglogene autotemce | 2024 |
J3394 | Injection, lovotibeglogene autotemcel, per treatment | Inj, lovotibeglogene autotem | 2024 |
J3396 | Injection, verteporfin, 0.1 mg | Verteporfin injection | 2005 |
J3397 | Injection, vestronidase alfa-vjbk, 1 mg | Inj., vestronidase alfa-vjbk | 2019 |
J3398 | Injection, voretigene neparvovec-rzyl, 1 billion vector genomes | Inj luxturna 1 billion vec g | 2019 |
J3399 | Injection, onasemnogene abeparvovec-xioi, per treatment, up to 5x10^15 vector genomes | Inj onase abepar-xioi treat | 2020 |
J3401 | Beremagene geperpavec-svdt for topical administration, containing nominal 5 x 10^9 pfu/ml vector genomes, per 0.1 ml | Vyjuvek 5x10^9pfu/ml, 0.1 ml | 2024 |
J3402 | Injection, remestemcel-l-rknd, per therapeutic dose | Inj. remestemcel-l-rknd/ td | 2025 |
J3403 | Revakinagene taroretcel-lwey, per implant | Revakinagene, per implant | 2025 |
J3404 | Injection, zopapogene imadenovec-drba suspension, per therapeutic dose | Inj zopapogene per ther dose | 2026 |
J3405 | Injection, onasemnogene abeparvovec-brve, per treatment | Inj onase abepar-brve treat | 2026 |
J3406 | Injection, omidubicel-onlv, per therapeutic dose | Inj omidubicel-onlv, tx dose | 2026 |
J3410 | Injection, hydroxyzine hcl, up to 25 mg | Hydroxyzine hcl injection | 1982 |
J3411 | Injection, thiamine hcl, 100 mg | Thiamine hcl 100 mg | 2004 |
J3415 | Injection, pyridoxine hcl, 100 mg | Pyridoxine hcl 100 mg | 2004 |
J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Vitamin b12 injection | 1986 |
J3424 | Injection, hydroxocobalamin, intravenous, 25 mg | Inj hydroxocobalamin iv 25mg | 2024 |
J3425 | Injection, hydroxocobalamin, intramuscular, 10 mcg | Hydroxocobalamin im 10mcg | 2024 |
J3430 | Injection, phytonadione (vitamin k), per 1 mg | Vitamin k phytonadione inj | 1982 |
J3465 | Injection, voriconazole, 10 mg | Injection, voriconazole | 2004 |
J3470 | Injection, hyaluronidase, up to 150 units | Hyaluronidase injection | 1982 |
J3471 | Injection, hyaluronidase, ovine, preservative free, per 1 usp unit (up to 999 usp units) | Ovine, up to 999 usp units | 2006 |
J3472 | Injection, hyaluronidase, ovine, preservative free, per 1000 usp units | Ovine, 1000 usp units | 2006 |
J3473 | Injection, hyaluronidase, recombinant, 1 usp unit | Hyaluronidase recombinant | 2007 |
J3475 | Injection, magnesium sulfate, per 500 mg | Inj magnesium sulfate | 1996 |
J3480 | Injection, potassium chloride, per 2 meq | Inj potassium chloride | 1996 |
J3485 | Injection, zidovudine, 10 mg | Zidovudine | 2001 |
J3486 | Injection, ziprasidone mesylate, 10 mg | Ziprasidone mesylate | 2004 |
J3489 | Injection, zoledronic acid, 1 mg | Zoledronic acid 1mg | 2014 |
J3490 | Unclassified drugs | Drugs unclassified injection | 1986 |
J3520 | Edetate disodium, per 150 mg | Edetate disodium per 150 mg | 1986 |
J3530 | Nasal vaccine inhalation | Nasal vaccine inhalation | 1986 |
J3535 | Drug administered through a metered dose inhaler | Metered dose inhaler drug | 1994 |
J3570 | Laetrile, amygdalin, vitamin b17 | Laetrile amygdalin vit b17 | 1986 |
J3590 | Unclassified biologics | Unclassified biologics | 2003 |
J3591 | Unclassified drug or biological used for esrd on dialysis | Esrd on dialysi drug/bio noc | 2019 |
J7030 | Infusion, normal saline solution , 1000 cc | Normal saline solution infus | 1982 |
J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | Normal saline solution infus | 1984 |
J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | 5% dextrose/normal saline | 1984 |
J7050 | Infusion, normal saline solution, 250 cc | Normal saline solution infus | 1982 |
J7060 | 5% dextrose/water (500 ml = 1 unit) | 5% dextrose/water | 1985 |
J7070 | Infusion, d5w, 1000 cc | D5w infusion | 1982 |
J7100 | Infusion, dextran 40, 500 ml | Dextran 40 infusion | 1982 |
J7110 | Infusion, dextran 75, 500 ml | Dextran 75 infusion | 1982 |
J7120 | Ringers lactate infusion, up to 1000 cc | Ringers lactate infusion | 1982 |
J7121 | 5% dextrose in lactated ringers infusion, up to 1000 cc | 5% dextrose in lac ringers | 2016 |
J7131 | Hypertonic saline solution, 1 ml | Hypertonic saline sol | 2012 |
J7165 | Injection, prothrombin complex concentrate, human-lans, per i.u. of factor ix activity | Inj, human-lans, per i.u | 2024 |
J7168 | Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity | Prothrombin complex kcentra | 2021 |
J7169 | Injection, coagulation factor xa (recombinant), inactivated-zhzo (andexxa), 10 mg | Inj andexxa, 10 mg | 2020 |
J7170 | Injection, emicizumab-kxwh, 0.5 mg | Inj., emicizumab-kxwh 0.5 mg | 2019 |
J7171 | Injection, adamts13, recombinant-krhn, 10 iu | Inj, adzynma, 10 iu | 2024 |
J7172 | Injection, marstacimab-hncq, 0.5 mg | Inj marstacim-hncq, 0.5 mg | 2025 |
J7173 | Injection, concizumab-mtci, 0.5 mg | Inj. concizumab-mtci, 0.5 mg | 2025 |
J7174 | Injection, fitusiran, 0.04 mg | Injection fitusiran 0.04 mg | 2025 |
J7175 | Injection, factor x, (human), 1 i.u. | Inj, factor x, (human), 1iu | 2017 |
J7176 | Injection, human fibrinogen - chmt (fesilty), 1 mg | Inj. fesilty, 1 mg | 2026 |
J7177 | Injection, human fibrinogen concentrate (fibryga), 1 mg | Inj., fibryga, 1 mg | 2019 |
J7178 | Injection, human fibrinogen concentrate, not otherwise specified, 1 mg | Inj human fibrinogen con nos | 2013 |
J7179 | Injection, von willebrand factor (recombinant), (vonvendi), 1 i.u. vwf:rco | Vonvendi inj 1 iu vwf:rco | 2017 |
J7180 | Injection, factor xiii (antihemophilic factor, human), 1 i.u. | Factor xiii anti-hem factor | 2012 |
J7181 | Injection, factor xiii a-subunit, (recombinant), per iu | Factor xiii recomb a-subunit | 2015 |
J7182 | Injection, factor viii, (antihemophilic factor, recombinant), (novoeight), per iu | Factor viii recomb novoeight | 2015 |
J7183 | Injection, von willebrand factor complex (human), wilate, 1 i.u. vwf:rco | Wilate injection | 2012 |
J7185 | Injection, factor viii (antihemophilic factor, recombinant) (xyntha), per i.u. | Xyntha inj | 2010 |
J7186 | Injection, antihemophilic factor viii/von willebrand factor complex (human), per factor viii i.u. | Antihemophilic viii/vwf comp | 2009 |
J7187 | Injection, von willebrand factor complex (humate-p), per iu vwf:rco | Humate-p, inj | 2007 |
J7188 | Injection, factor viii (antihemophilic factor, recombinant), (obizur), per i.u. | Factor viii recomb obizur | 2016 |
J7189 | Factor viia (antihemophilic factor, recombinant), (novoseven rt), 1 microgram | Factor viia recomb novoseven | 2006 |
J7190 | Factor viii (antihemophilic factor, human) per i.u. | Factor viii | 1986 |
J7191 | Factor viii (antihemophilic factor (porcine)), per i.u. | Factor viii (porcine) | 1996 |
J7192 | Factor viii (antihemophilic factor, recombinant) per i.u., not otherwise specified | Factor viii recombinant nos | 1994 |
J7193 | Factor ix (antihemophilic factor, purified, non-recombinant) per i.u. | Factor ix non-recombinant | 2002 |
J7194 | Factor ix, complex, per i.u. | Factor ix complex | 1986 |
J7195 | Injection, factor ix (antihemophilic factor, recombinant) per iu, not otherwise specified | Factor ix recombinant nos | 2002 |
J7196 | Injection, antithrombin recombinant, 50 i.u. | Antithrombin recombinant | 2011 |
J7197 | Antithrombin iii (human), per i.u. | Antithrombin iii injection | 1992 |
J7198 | Anti-inhibitor, per i.u. | Anti-inhibitor | 2000 |
J7199 | Hemophilia clotting factor, not otherwise classified | Hemophilia clot factor noc | 2000 |
J7200 | Injection, factor ix, (antihemophilic factor, recombinant), rixubis, per iu | Factor ix recombinan rixubis | 2015 |
J7201 | Injection, factor ix, fc fusion protein, (recombinant), alprolix, 1 i.u. | Factor ix alprolix recomb | 2015 |
J7202 | Injection, factor ix, albumin fusion protein, (recombinant), idelvion, 1 i.u. | Factor ix idelvion inj | 2017 |
J7203 | Injection factor ix, (antihemophilic factor, recombinant), glycopegylated, (rebinyn), 1 iu | Factor ix recomb gly rebinyn | 2019 |
J7204 | Injection, factor viii, antihemophilic factor (recombinant), (esperoct), glycopegylated-exei, per iu | Inj recombin esperoct per iu | 2020 |
J7205 | Injection, factor viii fc fusion protein (recombinant), per iu | Factor viii fc fusion recomb | 2016 |
J7207 | Injection, factor viii, (antihemophilic factor, recombinant), pegylated, 1 i.u. | Factor viii pegylated recomb | 2017 |
J7208 | Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl, (jivi), 1 i.u. | Inj. jivi 1 iu | 2019 |
J7209 | Injection, factor viii, (antihemophilic factor, recombinant), (nuwiq), 1 i.u. | Factor viii nuwiq recomb 1iu | 2017 |
J7210 | Injection, factor viii, (antihemophilic factor, recombinant), (afstyla), 1 i.u. | Inj, afstyla, 1 i.u. | 2018 |
J7211 | Injection, factor viii, (antihemophilic factor, recombinant), (kovaltry), 1 i.u. | Inj, kovaltry, 1 i.u. | 2018 |
J7212 | Factor viia (antihemophilic factor, recombinant)-jncw (sevenfact), 1 microgram | Factor viia recomb sevenfact | 2021 |
J7213 | Injection, coagulation factor ix (recombinant), ixinity, 1 i.u. | Inj, ixinity, 1 i.u. | 2023 |
J7214 | Injection, factor viii/von willebrand factor complex, recombinant (altuviiio), per factor viii i.u. | Altuviiio per factor viii iu | 2023 |
J7294 | Segesterone acetate and ethinyl estradiol 0.15mg, 0.013mg per 24 hours; yearly vaginal system, each | Seg acet and eth estr yearly | 2021 |
J7295 | Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, each | Eth estr and eton monthly | 2021 |
J7296 | Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mg | Kyleena, 19.5 mg | 2018 |
J7297 | Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg | Liletta, 52 mg | 2016 |
J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | Mirena, 52 mg | 2016 |
J7299 | Intrauterine copper contraceptive (miudella) | Intraut copp cont (miudella) | 2026 |
J7300 | Intrauterine copper contraceptive (paragard) | Intra copp contra (paragard) | 1986 |
J7301 | Levonorgestrel-releasing intrauterine contraceptive system (skyla), 13.5 mg | Skyla, 13.5 mg | 2014 |
J7304 | Contraceptive supply, hormone containing patch, each | Contraceptive hormone patch | 2005 |
J7306 | Levonorgestrel (contraceptive) implant system, including implants and supplies | Levonorgestrel implant sys | 2006 |
J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | Etonogestrel implant system | 2008 |
J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Aminolevulinic acid hcl top | 2002 |
J7311 | Injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mg | Inj., retisert, 0.01 mg | 2007 |
J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | Dexamethasone intra implant | 2011 |
J7313 | Injection, fluocinolone acetonide, intravitreal implant (iluvien), 0.01 mg | Inj., iluvien, 0.01 mg | 2016 |
J7314 | Injection, fluocinolone acetonide, intravitreal implant (yutiq), 0.01 mg | Inj., yutiq, 0.01 mg | 2019 |
J7315 | Mitomycin, ophthalmic, 0.2 mg | Ophthalmic mitomycin | 2013 |
J7316 | Injection, ocriplasmin, 0.125 mg | Inj, ocriplasmin, 0.125 mg | 2014 |
J7318 | Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | Inj, durolane 1 mg | 2019 |
J7320 | Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg | Genvisc 850, inj, 1mg | 2017 |
J7321 | Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | Hyalgan supartz visco-3 dose | 2008 |
J7322 | Hyaluronan or derivative, hymovis or hymovis one, for intra-articular injection, 1 mg | Hyaluronan, hymo or hymo one | 2017 |
J7323 | Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | Euflexxa inj per dose | 2008 |
J7324 | Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | Orthovisc inj per dose | 2008 |
J7325 | Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | Synvisc or synvisc-one | 2010 |
J7326 | Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | Gel-one | 2012 |
J7327 | Hyaluronan or derivative, monovisc, for intra-articular injection, per dose | Monovisc inj per dose | 2015 |
J7328 | Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | Gelsyn-3 injection 0.1 mg | 2016 |
J7329 | Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg | Inj, trivisc 1 mg | 2019 |
J7330 | Autologous cultured chondrocytes, implant | Cultured chondrocytes implnt | 2001 |
J7331 | Hyaluronan or derivative, synojoynt, for intra-articular injection, 1 mg | Synojoynt, inj., 1 mg | 2019 |
J7332 | Hyaluronan or derivative, triluron, for intra-articular injection, 1 mg | Inj., triluron, 1 mg | 2019 |
J7336 | Capsaicin 8% patch, per square centimeter | Capsaicin 8% patch | 2015 |
J7340 | Carbidopa 5 mg/levodopa 20 mg enteral suspension, 100 ml | Carbidopa levodopa ent 100ml | 2016 |
J7342 | Instillation, ciprofloxacin otic suspension, 6 mg | Ciprofloxacin otic susp 6 mg | 2017 |
J7345 | Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Aminolevulinic acid, 10% gel | 2018 |
J7351 | Injection, bimatoprost, intracameral implant, 1 microgram | Inj bimatoprost itc imp1mcg | 2020 |
J7352 | Afamelanotide implant, 1 mg | Afamelanotide implant, 1 mg | 2021 |
J7353 | Anacaulase-bcdb, 8.8% gel, 1 gram | Anacaulase-bcdb 8.8% gel 1 g | 2023 |
J7354 | Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg) | Cantharidin top, applicator | 2024 |
J7355 | Injection, travoprost, intracameral implant, 1 microgram | Inj travoprost intra impl | 2024 |
J7356 | Injection, foscarbidopa 0.25 mg/foslevodopa 5 mg | Inj foscarb/foslevodopa 5 mg | 2025 |
J7402 | Mometasone furoate sinus implant, (sinuva), 10 micrograms | Mometasone sinus sinuva | 2021 |
J7500 | Azathioprine, oral, 50 mg | Azathioprine oral 50mg | 1988 |
J7501 | Azathioprine, parenteral, 100 mg | Azathioprine parenteral | 1988 |
J7502 | Cyclosporine, oral, 100 mg | Cyclosporine oral 100 mg | 2000 |
J7503 | Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg | Tacrol envarsus ex rel oral | 2016 |
J7504 | Lymphocyte immune globulin, antithymocyte globulin, equine, parenteral, 250 mg | Lymphocyte immune globulin | 1988 |
J7507 | Tacrolimus, immediate release, oral, 1 mg | Tacrolimus imme rel oral 1mg | 1995 |
J7508 | Tacrolimus, extended release, (astagraf xl), oral, 0.1 mg | Tacrol astagraf ex rel oral | 2014 |
J7509 | Methylprednisolone oral, per 4 mg | Methylprednisolone oral | 1996 |
J7510 | Prednisolone oral, per 5 mg | Prednisolone oral per 5 mg | 1996 |
J7511 | Lymphocyte immune globulin, antithymocyte globulin, rabbit, parenteral, 25 mg | Antithymocyte globuln rabbit | 2002 |
J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | Prednisone ir or dr oral 1mg | 2016 |
J7515 | Cyclosporine, oral, 25 mg | Cyclosporine oral 25 mg | 2000 |
J7516 | Injection, cyclosporine, 250 mg | Inj, cyclosporine 250mg | 2000 |
J7518 | Mycophenolic acid, oral, 180 mg | Mycophenolic acid | 2005 |
J7520 | Sirolimus, oral, 1 mg | Sirolimus, oral | 2001 |
J7521 | Tacrolimus, granules, oral suspension, 0.1 mg | Tacrolim granules oral susp | 2025 |
J7524 | Mycophenolate mofetil, oral, 5 mg | Mycophenol mofetil oral 5 mg | 2026 |
J7525 | Tacrolimus, parenteral, 5 mg | Tacrolimus injection | 2001 |
J7526 | Injection, mycophenolate mofetil, 5 mg | Inj mycophenola mofetil 5 mg | 2026 |
J7527 | Everolimus, oral, 0.25 mg | Oral everolimus | 2013 |
J7529 | Mycophenolate mofetil, for suspension, oral, 5 mg | Mycop mofetil susp oral 5 mg | 2026 |
J7530 | Mycophenolate mofetil (myhibbin), oral suspension, 5 mg | Mycophenolat (myhibbin) 5 mg | 2026 |
J7531 | Prednisolone sodium phosphate, orally disintegrating tablet, 1 mg | Pred sod pho ora dis ta 1 mg | 2026 |
J7599 | Immunosuppressive drug, not otherwise classified | Immunosuppressive drug noc | 1996 |
J7601 | Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg | Ensifentrine inh 3 mg | 2025 |
J7604 | Acetylcysteine, inhalation solution, compounded product, administered through dme, unit dose form, per gram | Acetylcysteine comp unit | 2008 |
J7605 | Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms | Arformoterol non-comp unit | 2008 |
J7606 | Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms | Formoterol fumarate, inh | 2009 |
J7607 | Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg | Levalbuterol comp con | 2007 |
J7608 | Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram | Acetylcysteine non-comp unit | 2000 |
J7609 | Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg | Albuterol comp unit | 2007 |
J7610 | Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg | Albuterol comp con | 2007 |
J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | Albuterol non-comp con | 2005 |
J7612 | Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg | Levalbuterol non-comp con | 2005 |
J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | Albuterol non-comp unit | 2005 |
J7614 | Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg | Levalbuterol non-comp unit | 2005 |
J7615 | Levalbuterol, inhalation solution, compounded product, administered through dme, unit dose, 0.5 mg | Levalbuterol comp unit | 2007 |
J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | Albuterol ipratrop non-comp | 2006 |
J7622 | Beclomethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram | Beclomethasone comp unit | 2002 |
J7624 | Betamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram | Betamethasone comp unit | 2002 |
J7626 | Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg | Budesonide non-comp unit | 2002 |
J7627 | Budesonide, inhalation solution, compounded product, administered through dme, unit dose form, up to 0.5 mg | Budesonide comp unit | 2006 |
J7628 | Bitolterol mesylate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram | Bitolterol mesylate comp con | 2000 |
J7629 | Bitolterol mesylate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram | Bitolterol mesylate comp unt | 2000 |
J7631 | Cromolyn sodium, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams | Cromolyn sodium noncomp unit | 2000 |
J7632 | Cromolyn sodium, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams | Cromolyn sodium comp unit | 2008 |
J7633 | Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 0.25 milligram | Budesonide non-comp con | 2003 |
J7634 | Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram | Budesonide comp con | 2007 |
J7635 | Atropine, inhalation solution, compounded product, administered through dme, concentrated form, per milligram | Atropine comp con | 2000 |
J7636 | Atropine, inhalation solution, compounded product, administered through dme, unit dose form, per milligram | Atropine comp unit | 2000 |
J7637 | Dexamethasone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram | Dexamethasone comp con | 2000 |
J7638 | Dexamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram | Dexamethasone comp unit | 2000 |
J7639 | Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | Dornase alfa non-comp unit | 2000 |
J7640 | Formoterol, inhalation solution, compounded product, administered through dme, unit dose form, 12 micrograms | Formoterol comp unit | 2006 |
J7641 | Flunisolide, inhalation solution, compounded product, administered through dme, unit dose, per milligram | Flunisolide comp unit | 2002 |
J7642 | Glycopyrrolate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram | Glycopyrrolate comp con | 2000 |
J7643 | Glycopyrrolate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram | Glycopyrrolate comp unit | 2000 |
J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | Ipratropium bromide non-comp | 2000 |
J7645 | Ipratropium bromide, inhalation solution, compounded product, administered through dme, unit dose form, per milligram | Ipratropium bromide comp | 2007 |
J7647 | Isoetharine hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram | Isoetharine comp con | 2007 |
J7648 | Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram | Isoetharine non-comp con | 2000 |
J7649 | Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | Isoetharine non-comp unit | 2000 |
J7650 | Isoetharine hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram | Isoetharine comp unit | 2007 |
J7657 | Isoproterenol hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram | Isoproterenol comp con | 2007 |
J7658 | Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram | Isoproterenol non-comp con | 2000 |
J7659 | Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | Isoproterenol non-comp unit | 2000 |
J7660 | Isoproterenol hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram | Isoproterenol comp unit | 2007 |
J7665 | Mannitol, administered through an inhaler, 5 mg | Mannitol for inhaler | 2012 |
J7667 | Metaproterenol sulfate, inhalation solution, compounded product, concentrated form, per 10 milligrams | Metaproterenol comp con | 2007 |
J7668 | Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 10 milligrams | Metaproterenol non-comp con | 2000 |
J7669 | Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams | Metaproterenol non-comp unit | 2000 |
J7670 | Metaproterenol sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams | Metaproterenol comp unit | 2007 |
J7674 | Methacholine chloride administered as inhalation solution through a nebulizer, per 1 mg | Methacholine chloride, neb | 2005 |
J7676 | Pentamidine isethionate, inhalation solution, compounded product, administered through dme, unit dose form, per 300 mg | Pentamidine comp unit dose | 2008 |
J7677 | Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram | Revefenacin inh non-com 1mcg | 2019 |
J7680 | Terbutaline sulfate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram | Terbutaline sulf comp con | 2000 |
J7681 | Terbutaline sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram | Terbutaline sulf comp unit | 2000 |
J7682 | Tobramycin, inhalation solution, fda-approved final product, non-compounded, unit dose form, administered through dme, per 300 milligrams | Tobramycin non-comp unit | 2000 |
J7683 | Triamcinolone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram | Triamcinolone comp con | 2000 |
J7684 | Triamcinolone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram | Triamcinolone comp unit | 2000 |
J7685 | Tobramycin, inhalation solution, compounded product, administered through dme, unit dose form, per 300 milligrams | Tobramycin comp unit | 2007 |
J7686 | Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mg | Treprostinil, non-comp unit | 2011 |
J7699 | Noc drugs, inhalation solution administered through dme | Inhalation solution for dme | 1993 |
J7799 | Noc drugs, other than inhalation drugs, administered through dme | Non-inhalation drug for dme | 1993 |
J7999 | Compounded drug, not otherwise classified | Compounded drug, noc | 2016 |
J8498 | Antiemetic drug, rectal/suppository, not otherwise specified | Antiemetic rectal/supp nos | 2006 |
J8499 | Prescription drug, oral, non chemotherapeutic, nos | Oral prescrip drug non chemo | 1995 |
J8501 | Aprepitant, oral, 5 mg | Oral aprepitant | 2005 |
J8502 | Injection, aprepitant (aponvie), 1 mg | Inj, aponvie, 1 mg | 2026 |
J8510 | Busulfan; oral, 2 mg | Oral busulfan | 2000 |
J8515 | Cabergoline, oral, 0.25 mg | Cabergoline, oral 0.25mg | 2006 |
J8522 | Capecitabine, oral, 50 mg | Capecitabine, oral, 50 mg | 2024 |
J8530 | Cyclophosphamide; oral, 25 mg | Cyclophosphamide oral 25 mg | 1995 |
J8540 | Dexamethasone, oral, 0.25 mg | Oral dexamethasone | 2006 |
J8541 | Dexamethasone (hemady), oral, 0.25 mg | Oral, hemady, 0.25 mg | 2024 |
J8560 | Etoposide; oral, 50 mg | Etoposide oral 50 mg | 1995 |
J8565 | Gefitinib, oral, 250 mg | Gefitinib oral | 2005 |
J8597 | Antiemetic drug, oral, not otherwise specified | Antiemetic drug oral nos | 2006 |
J8600 | Melphalan; oral, 2 mg | Melphalan oral 2 mg | 1995 |
J8610 | Methotrexate; oral, 2.5 mg | Methotrexate oral 2.5 mg | 1995 |
J8611 | Methotrexate (jylamvo), oral, 2.5 mg | Oral methotrexate (jylamvo) | 2024 |
J8612 | Methotrexate (xatmep), oral, 2.5 mg | Oral methotrexate (xatmep) | 2024 |
J8655 | Netupitant 300 mg and palonosetron 0.5 mg, oral | Oral netupitant, palonosetro | 2016 |
J8670 | Rolapitant, oral, 1 mg | Rolapitant, oral, 1mg | 2017 |
J8700 | Temozolomide, oral, 5 mg | Temozolomide | 2001 |
J8705 | Topotecan, oral, 0.25 mg | Topotecan oral | 2009 |
J8999 | Prescription drug, oral, chemotherapeutic, nos | Oral prescription drug chemo | 1995 |
J9000 | Injection, doxorubicin hydrochloride, 10 mg | Doxorubicin hcl injection | 1984 |
J9003 | Leuprolide injectable (camcevi etm), 1 mg | Leupro inj, camcevi etm, 1mg | 2026 |
J9011 | Injection, datopotamab deruxtecan-dlnk, 1 mg | Datopotamab deruxtecan, 1 mg | 2025 |
J9015 | Injection, aldesleukin, per single use vial | Aldesleukin injection | 1996 |
J9017 | Injection, arsenic trioxide, 1 mg | Arsenic trioxide injection | 2002 |
J9021 | Injection, asparaginase, recombinant, (rylaze), 0.1 mg | Inj, aspara, rylaze, 0.1 mg | 2022 |
J9022 | Injection, atezolizumab, 10 mg | Inj, atezolizumab,10 mg | 2018 |
J9023 | Injection, avelumab, 10 mg | Injection, avelumab, 10 mg | 2018 |
J9024 | Injection, atezolizumab, 5 mg and hyaluronidase-tqjs | Inj atezolizumb 5mg hya-tqjs | 2025 |
J9025 | Injection, azacitidine, 1 mg | Azacitidine injection | 2006 |
J9026 | Injection, tarlatamab-dlle, 1 mg | Inj, tarlatamab-dlle, 1 mg | 2025 |
J9027 | Injection, clofarabine, 1 mg | Clofarabine injection | 2006 |
J9028 | Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram | Inj, nogapendekin pmln, 1mcg | 2025 |
J9029 | Intravesical instillation, nadofaragene firadenovec-vncg, per therapeutic dose | Instill adstiladrin, tx dose | 2023 |
J9030 | Bcg live intravesical instillation, 1 mg | Bcg live intravesical 1mg | 2019 |
J9032 | Injection, belinostat, 10 mg | Injection, belinostat, 10mg | 2016 |
J9033 | Injection, bendamustine hydrochloride, not otherwise specified, 1 mg | Inj, bendamustine (nos) 1mg | 2009 |
J9034 | Injection, bendamustine hcl (bendeka), 1 mg | Inj., bendeka 1 mg | 2017 |
J9035 | Injection, bevacizumab, 10 mg | Bevacizumab injection | 2005 |
J9036 | Injection, bendamustine hydrochloride, (belrapzo/bendamustine), 1 mg | Inj. belrapzo/bendamustine | 2019 |
J9038 | Injection, axatilimab-csfr, 0.1 mg | Inj axatilimab-csfr 0.1 mg | 2025 |
J9039 | Injection, blinatumomab, 1 microgram | Injection, blinatumomab | 2016 |
J9040 | Injection, bleomycin sulfate, 15 units | Bleomycin sulfate injection | 1984 |
J9041 | Injection, bortezomib, 0.1 mg | Injection, bortezomib, 0.1mg | 2005 |
J9042 | Injection, brentuximab vedotin, 1 mg | Brentuximab vedotin inj | 2013 |
J9043 | Injection, cabazitaxel, 1 mg | Cabazitaxel injection | 2012 |
J9045 | Injection, carboplatin, 50 mg | Carboplatin injection | 1990 |
J9046 | Injection, bortezomib (dr. reddy's), not therapeutically equivalent to j9041, 0.1 mg | Inj, bortezomib, dr. reddy's | 2023 |
J9047 | Injection, carfilzomib, 1 mg | Injection, carfilzomib, 1 mg | 2014 |
J9048 | Injection, bortezomib (fresenius kabi), not therapeutically equivalent to j9041, 0.1 mg | Inj, bortezomib freseniuskab | 2023 |
J9049 | Injection, bortezomib (hospira), not therapeutically equivalent to j9041, 0.1 mg | Inj, bortezomib, hospira | 2023 |
J9050 | Injection, carmustine, 100 mg | Carmustine injection | 1984 |
J9051 | Injection, bortezomib (maia), not therapeutically equivalent to j9041, 0.1 mg | Inj, bortezomib (maia) | 2023 |
J9052 | Injection, carmustine (accord), not therapeutically equivalent to j9050, 100 mg | Inj, carmustine (accord) | 2024 |
J9053 | Injection, belantamab mafodotin-blmf, 0.1 mg | Inj belantamab mafodot blmf | 2026 |
J9054 | Injection, bortezomib (boruzu), 0.1 mg | Inj bortezomib boruzu 0.1 mg | 2025 |
J9055 | Injection, cetuximab, 10 mg | Cetuximab injection | 2005 |
J9056 | Injection, bendamustine hydrochloride (vivimusta), 1 mg | Inj, vivimusta, 1 mg | 2023 |
J9057 | Injection, copanlisib, 1 mg | Inj., copanlisib, 1 mg | 2019 |
J9060 | Injection, cisplatin, powder or solution, 10 mg | Cisplatin 10 mg injection | 1984 |
J9061 | Injection, amivantamab-vmjw, 2 mg | Inj, amivantamab-vmjw | 2022 |
J9062 | Injection, amivantamab 5 mg and hyaluronidase-lpuj | Inj amivantamab 5mg hyaluron | 2026 |
J9063 | Injection, mirvetuximab soravtansine-gynx, 1 mg | Inj, elahere, 1 mg | 2023 |
J9064 | Injection, cabazitaxel (sandoz), not therapeutically equivalent to j9043, 1 mg | Inj, cabazitaxel (sandoz) | 2023 |
J9065 | Injection, cladribine, per 1 mg | Inj cladribine per 1 mg | 1995 |
J9066 | Injection, bendamustine hydrochloride (avyxa), 1 mg | Inj bendamustine, avyxa 1mg | 2026 |
J9071 | Injection, cyclophosphamide (auromedics), 5 mg | Inj cyclophosphamd auromedic | 2022 |
J9072 | Injection, cyclophosphamide (frindovyx), 5 mg | Inj cyclophos frindovyx 5 mg | 2024 |
J9073 | Injection, cyclophosphamide (dr. reddy's), 5 mg | Inj cyclophos dr reddys 5 mg | 2024 |
J9074 | Injection, cyclophosphamide (sandoz), 5 mg | Inj, cyclophosphamd, sandoz | 2024 |
J9075 | Injection, cyclophosphamide, not otherwise specified, 5 mg | Inj, cyclophosphamide, nos | 2024 |
J9076 | Injection, cyclophosphamide (baxter), 5 mg | Inj, cyclophos (baxter) 5mg | 2025 |
J9100 | Injection, cytarabine, 100 mg | Cytarabine hcl 100 mg inj | 1986 |
J9118 | Injection, calaspargase pegol-mknl, 10 units | Inj. calaspargase pegol-mknl | 2019 |
J9119 | Injection, cemiplimab-rwlc, 1 mg | Inj., cemiplimab-rwlc, 1 mg | 2019 |
J9120 | Injection, dactinomycin, 0.5 mg | Dactinomycin injection | 1984 |
J9130 | Dacarbazine, 100 mg | Dacarbazine 100 mg inj | 1986 |
J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | Daratumumab, hyaluronidase | 2021 |
J9145 | Injection, daratumumab, 10 mg | Injection, daratumumab 10 mg | 2017 |
J9150 | Injection, daunorubicin, 10 mg | Daunorubicin injection | 1986 |
J9153 | Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine | Inj daunorubicin, cytarabine | 2019 |
J9155 | Injection, degarelix, 1 mg | Degarelix injection | 2010 |
J9161 | Injection, denileukin diftitox-cxdl, 1 mcg | Inj denileuk difti-cxdl 1mcg | 2025 |
J9171 | Injection, docetaxel, 1 mg | Docetaxel injection | 2010 |
J9172 | Injection, docetaxel (docivyx), 1 mg | Docetaxel (docivyx), 1 mg | 2024 |
J9173 | Injection, durvalumab, 10 mg | Inj., durvalumab, 10 mg | 2019 |
J9174 | Injection, docetaxel (beizray), 1 mg | Inj, docetaxel (beizray) 1mg | 2025 |
J9175 | Injection, elliotts' b solution, 1 ml | Elliotts b solution per ml | 2006 |
J9176 | Injection, elotuzumab, 1 mg | Injection, elotuzumab, 1mg | 2017 |
J9177 | Injection, enfortumab vedotin-ejfv, 0.25 mg | Inj enfort vedo-ejfv 0.25mg | 2020 |
J9178 | Injection, epirubicin hcl, 2 mg | Inj, epirubicin hcl, 2 mg | 2004 |
J9179 | Injection, eribulin mesylate, 0.1 mg | Eribulin mesylate injection | 2012 |
J9183 | Gemcitabine intravesical system, 225 mg | Gemcitabine intravesical sys | 2026 |
J9184 | Injection, gemcitabine hydrochloride (avyxa), 200 mg | Inj gemcitabin (avyxa) 200mg | 2026 |
J9185 | Injection, fludarabine phosphate, 50 mg | Fludarabine phosphate inj | 1994 |
J9186 | Injection, etoposide (avyxa), 1 mg | Inj etoposide (avyxa), 1 mg | 2026 |
J9187 | Injection, etoposide, 1 mg | Inj, etoposide, 1 mg | 2026 |
J9191 | Injection, fluorouracil (avyxa), 10 mg | Inj fluorouracil (avyxa)10mg | 2026 |
J9192 | Injection, fluorouracil, 10 mg | Inj, fluorouracil, 10 mg | 2026 |
J9196 | Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mg | Inj gemcitabine hcl (accord) | 2023 |
J9198 | Injection, gemcitabine hydrochloride, (infugem), 100 mg | Inj. infugem, 100 mg | 2020 |
J9200 | Injection, floxuridine, 500 mg | Floxuridine injection | 1984 |
J9201 | Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | In gemcitabine hcl nos 200mg | 1998 |
J9202 | Goserelin acetate implant, per 3.6 mg | Goserelin acetate implant | 1991 |
J9203 | Injection, gemtuzumab ozogamicin, 0.1 mg | Gemtuzumab ozogamicin 0.1 mg | 2018 |
J9204 | Injection, mogamulizumab-kpkc, 1 mg | Inj mogamulizumab-kpkc, 1 mg | 2019 |
J9205 | Injection, irinotecan liposome, 1 mg | Inj irinotecan liposome 1 mg | 2017 |
J9206 | Injection, irinotecan, 20 mg | Irinotecan injection | 1998 |
J9207 | Injection, ixabepilone, 1 mg | Ixabepilone injection | 2009 |
J9208 | Injection, ifosfamide, 1 gram | Ifosfamide injection | 1990 |
J9209 | Injection, mesna, 200 mg | Mesna injection | 1990 |
J9210 | Injection, emapalumab-lzsg, 1 mg | Inj., emapalumab-lzsg, 1 mg | 2019 |
J9211 | Injection, idarubicin hydrochloride, 5 mg | Idarubicin hcl injection | 1993 |
J9213 | Injection, interferon, alfa-2a, recombinant, 3 million units | Interferon alfa-2a inj | 1993 |
J9214 | Injection, interferon, alfa-2b, recombinant, 1 million units | Interferon alfa-2b inj | 1993 |
J9215 | Injection, interferon, alfa-n3, (human leukocyte derived), 250,000 iu | Interferon alfa-n3 inj | 1993 |
J9216 | Injection, interferon, gamma 1-b, 3 million units | Interferon gamma 1-b inj | 1993 |
J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Leuprolide acetate suspnsion | 1991 |
J9218 | Leuprolide acetate, per 1 mg | Leuprolide acetate injeciton | 1990 |
J9219 | Leuprolide acetate implant, 65 mg | Leuprolide acetate implant | 2001 |
J9220 | Injection, indigotindisulfonate sodium, 1 mg | Indigotindisulfonate sod 1mg | 2025 |
J9223 | Injection, lurbinectedin, 0.1 mg | Inj. lurbinectedin, 0.1 mg | 2021 |
J9225 | Histrelin implant (vantas), 50 mg | Vantas implant | 2006 |
J9226 | Histrelin implant (supprelin la), 50 mg | Supprelin la implant | 2008 |
J9227 | Injection, isatuximab-irfc, 10 mg | Inj. isatuximab-irfc 10 mg | 2020 |
J9228 | Injection, ipilimumab, 1 mg | Ipilimumab injection | 2012 |
J9229 | Injection, inotuzumab ozogamicin, 0.1 mg | Inj inotuzumab ozogam 0.1 mg | 2019 |
J9230 | Injection, mechlorethamine hydrochloride, (nitrogen mustard), 10 mg | Mechlorethamine hcl inj | 1986 |
J9232 | Injection, docetaxel (hospira), not therapeutically equivalent to j9171, 1 mg | Inj docetaxel (hospira) 1 mg | 2026 |
J9245 | Injection, melphalan hydrochloride, not otherwise specified, 50 mg | Inj melpha hydroch nos 50 mg | 1995 |
J9246 | Injection, melphalan (evomela), 1 mg | Inj., evomela, 1 mg | 2020 |
J9248 | Injection, melphalan (hepzato), 1 mg | Inj melphalan (hepzato) 1 mg | 2024 |
J9249 | Injection, melphalan (apotex), 1 mg | Inj, melphalan (apotex) 1 mg | 2024 |
J9255 | Injection, methotrexate (accord), not therapeutically equivalent to j9260, 50 mg | Inj, methotrexate (accord) | 2024 |
J9256 | Injection, nipocalimab-aahu, 3 mg | Inj, nipocalimab-aahu, 3 mg | 2026 |
J9260 | Injection, methotrexate sodium, 50 mg | Inj methotrexate sodium 50mg | 1984 |
J9261 | Injection, nelarabine, 50 mg | Nelarabine injection | 2007 |
J9262 | Injection, omacetaxine mepesuccinate, 0.01 mg | Inj, omacetaxine mep, 0.01mg | 2014 |
J9263 | Injection, oxaliplatin, 0.5 mg | Oxaliplatin | 2004 |
J9264 | Injection, paclitaxel protein-bound particles, 1 mg | Paclitaxel protein bound | 2006 |
J9266 | Injection, pegaspargase, per single dose vial | Pegaspargase injection | 1996 |
J9267 | Injection, paclitaxel, 1 mg | Paclitaxel injection | 2015 |
J9268 | Injection, pentostatin, 10 mg | Pentostatin injection | 1994 |
J9269 | Injection, tagraxofusp-erzs, 10 micrograms | Inj. tagraxofusp-erzs 10 mcg | 2019 |
J9271 | Injection, pembrolizumab, 1 mg | Inj pembrolizumab | 2016 |
J9272 | Injection, dostarlimab-gxly, 10 mg | Inj, dostarlimab-gxly, 10 mg | 2022 |
J9273 | Injection, tisotumab vedotin-tftv, 1 mg | Inj tisotu vedotin-tftv, 1mg | 2022 |
J9274 | Injection, tebentafusp-tebn, 1 microgram | Inj, tebentafusp-tebn, 1 mcg | 2022 |
J9275 | Injection, cosibelimab-ipdl, 2 mg | Inj cosibelimab-ipdl, 2 mg | 2025 |
J9276 | Injection, zanidatamab-hrii, 2 mg | Inj zanidatamab-hrii, 2 mg | 2025 |
J9277 | Injection, pembrolizumab, 1 mg and berahyaluronidase alfa-pmph | Pembrolizumab 1mg berahyalur | 2026 |
J9278 | Injection, carboplatin (avyxa), 1 mg | Inj, carboplatin (avyxa) | 2026 |
J9280 | Injection, mitomycin, 5 mg | Mitomycin injection | 1986 |
J9281 | Mitomycin pyelocalyceal instillation, 1 mg | Mitomycin instillation | 2021 |
J9282 | Mitomycin, intravesical instillation, 1 mg | Mitomycin intravesical inst | 2026 |
J9285 | Injection, olaratumab, 10 mg | Inj, olaratumab, 10 mg | 2018 |
J9286 | Injection, glofitamab-gxbm, 2.5 mg | Inj glofitamab gxbm, 2.5 mg | 2024 |
J9289 | Injection, nivolumab, 2 mg and hyaluronidase-nvhy | Inj nivolumab 2 mg hyaluron | 2025 |
J9292 | Injection, pemetrexed dipotassium, 10 mg | Inj, pemetrexed dipotassium | 2025 |
J9293 | Injection, mitoxantrone hydrochloride, per 5 mg | Mitoxantrone hydrochl / 5 mg | 1990 |
J9294 | Injection, pemetrexed (hospira), not therapeutically equivalent to j9305, 10 mg | Inj pemetrexed, hospira 10mg | 2023 |
J9295 | Injection, necitumumab, 1 mg | Injection, necitumumab, 1 mg | 2017 |
J9296 | Injection, pemetrexed (accord), not therapeutically equivalent to j9305, 10 mg | Inj pemetrexed (accord) 10mg | 2023 |
J9297 | Injection, pemetrexed (sandoz), not therapeutically equivalent to j9305, 10 mg | Inj pemetrexed (sandoz) 10mg | 2023 |
J9298 | Injection, nivolumab and relatlimab-rmbw, 3 mg/1 mg | Inj nivol relatlimab 3mg/1mg | 2022 |
J9299 | Injection, nivolumab, 1 mg | Injection, nivolumab | 2016 |
J9301 | Injection, obinutuzumab, 10 mg | Obinutuzumab inj | 2015 |
J9302 | Injection, ofatumumab, 10 mg | Ofatumumab injection | 2011 |
J9303 | Injection, panitumumab, 10 mg | Panitumumab injection | 2008 |
J9304 | Injection, pemetrexed (pemfexy), 10 mg | Inj. pemetrexed, 10 mg | 2020 |
J9305 | Injection, pemetrexed, not otherwise specified, 10 mg | Inj. pemetrexed nos 10mg | 2005 |
J9306 | Injection, pertuzumab, 1 mg | Injection, pertuzumab, 1 mg | 2014 |
J9307 | Injection, pralatrexate, 1 mg | Pralatrexate injection | 2011 |
J9308 | Injection, ramucirumab, 5 mg | Injection, ramucirumab | 2016 |
J9309 | Injection, polatuzumab vedotin-piiq, 1 mg | Inj, polatuzumab vedotin 1mg | 2020 |
J9311 | Injection, rituximab 10 mg and hyaluronidase | Inj rituximab, hyaluronidase | 2019 |
J9312 | Injection, rituximab, 10 mg | Inj., rituximab, 10 mg | 2019 |
J9313 | Injection, moxetumomab pasudotox-tdfk, 0.01 mg | Inj., lumoxiti, 0.01 mg | 2019 |
J9314 | Injection, pemetrexed (teva), not therapeutically equivalent to j9305, 10 mg | Inj pemetrexed (teva) 10mg | 2023 |
J9316 | Injection, pertuzumab, trastuzumab, and hyaluronidase-zzxf, per 10 mg | Pertuzu, trastuzu, 10 mg | 2021 |
J9317 | Injection, sacituzumab govitecan-hziy, 2.5 mg | Sacituzumab govitecan-hziy | 2021 |
J9318 | Injection, romidepsin, non-lyophilized, 0.1 mg | Inj romidepsin non-lyo 0.1mg | 2021 |
J9319 | Injection, romidepsin, lyophilized, 0.1 mg | Inj romidepsin lyophil 0.1mg | 2021 |
J9320 | Injection, streptozocin, 1 gram | Streptozocin injection | 1986 |
J9321 | Injection, epcoritamab-bysp, 0.16 mg | Inj epcoritamab-bysp 0.16 mg | 2024 |
J9322 | Injection, pemetrexed (bluepoint), not therapeutically equivalent to j9305, 10 mg | Inj pemetrexed (bluepoint) | 2023 |
J9323 | Injection, pemetrexed ditromethamine, 10 mg | Inj pemetrexed ditromethamin | 2023 |
J9324 | Injection, pemetrexed (pemrydi rtu), 10 mg | Inj, pemrydi rtu, 10 mg | 2024 |
J9325 | Injection, talimogene laherparepvec, per 1 million plaque forming units | Inj talimogene laherparepvec | 2017 |
J9326 | Injection, telisotuzumab vedotin-tllv, 1 mg | Telisotuzumab vedotin-tllv | 2026 |
J9328 | Injection, temozolomide, 1 mg | Temozolomide injection | 2010 |
J9329 | Injection, tislelizumab-jsgr, 1mg | Inj, tislelizumab-jsgr | 2024 |
J9330 | Injection, temsirolimus, 1 mg | Temsirolimus injection | 2009 |
J9331 | Injection, sirolimus protein-bound particles, 1 mg | Inj sirolimus prot part 1 mg | 2022 |
J9332 | Injection, efgartigimod alfa-fcab, 2mg | Inj efgartigimod 2mg | 2022 |
J9333 | Injection, rozanolixizumab-noli, 1 mg | Inj rozanolixizum-noli 1 mg | 2024 |
J9334 | Injection, efgartigimod alfa, 2 mg and hyaluronidase-qvfc | Inj efgart-alfa 2mg hya-qvfc | 2024 |
J9341 | Injection, thiotepa (tepylute), 1 mg | Inj thiotepa (tepylute) 1 mg | 2025 |
J9342 | Injection, thiotepa, not otherwise specified, 1 mg | Inj thiotepa nos 1 mg | 2025 |
J9345 | Injection, retifanlimab-dlwr, 1 mg | Inj, retifanlimab-dlwr, 1 mg | 2023 |
J9347 | Injection, tremelimumab-actl, 1 mg | Inj, tremelimumab-actl, 1 mg | 2023 |
J9348 | Injection, naxitamab-gqgk, 1 mg | Inj. naxitamab-gqgk, 1 mg | 2021 |
J9349 | Injection, tafasitamab-cxix, 2 mg | Inj., tafasitamab-cxix | 2021 |
J9350 | Injection, mosunetuzumab-axgb, 1 mg | Inj mosunetuzumab-axgb, 1 mg | 2023 |
J9351 | Injection, topotecan, 0.1 mg | Topotecan injection | 2011 |
J9353 | Injection, margetuximab-cmkb, 5 mg | Inj. margetuximab-cmkb, 5 mg | 2021 |
J9354 | Injection, ado-trastuzumab emtansine, 1 mg | Inj, ado-trastuzumab emt 1mg | 2014 |
J9355 | Injection, trastuzumab, excludes biosimilar, 10 mg | Inj trastuzumab excl biosimi | 2000 |
J9356 | Injection, trastuzumab, 10 mg and hyaluronidase-oysk | Inj. herceptin hylecta, 10mg | 2019 |
J9357 | Injection, valrubicin, intravesical, 200 mg | Valrubicin injection | 2000 |
J9358 | Injection, fam-trastuzumab deruxtecan-nxki, 1 mg | Inj fam-trastu deru-nxki 1mg | 2020 |
J9359 | Injection, loncastuximab tesirine-lpyl, 0.075 mg | Inj lon tesirin-lpyl 0.075mg | 2022 |
J9360 | Injection, vinblastine sulfate, 1 mg | Vinblastine sulfate inj | 1986 |
J9361 | Injection, efbemalenograstim alfa-vuxw, 0.5 mg | Inj, efbemalenograstim alfa- | 2024 |
J9362 | Injection, trabectedin, 0.01 mg | Inj, trabectedin, 0.01 mg | 2026 |
J9370 | Vincristine sulfate, 1 mg | Vincristine sulfate 1 mg inj | 1986 |
J9376 | Injection, pozelimab-bbfg, 1 mg | Inj pozelimab-bbfg, 1 mg | 2024 |
J9380 | Injection, teclistamab-cqyv, 0.5 mg | Inj teclistamab cqyv 0.5 mg | 2023 |
J9381 | Injection, teplizumab-mzwv, 5 mcg | Inj teplizumab mzwv 5 mcg | 2023 |
J9382 | Injection, zenocutuzumab-zbco, 1 mg | Inj zenocutuzumab-zbco 1 mg | 2025 |
J9390 | Injection, vinorelbine tartrate, 10 mg | Vinorelbine tartrate inj | 1996 |
J9393 | Injection, fulvestrant (teva), not therapeutically equivalent to j9395, 25 mg | Inj, fulvestrant (teva) | 2023 |
J9394 | Injection, fulvestrant (fresenius kabi) not therapeutically equivalent to j9395, 25 mg | Inj, fulvestrant (fresenius) | 2023 |
J9395 | Injection, fulvestrant, 25 mg | Injection, fulvestrant | 2004 |
J9400 | Injection, ziv-aflibercept, 1 mg | Inj, ziv-aflibercept, 1mg | 2014 |
J9600 | Injection, porfimer sodium, 75 mg | Porfimer sodium injection | 1998 |
J9601 | Injection, linvoseltamab-gcpt, 1 mg | Inj linvoseltamab-gcpt 1 mg | 2026 |
J9999 | Not otherwise classified, antineoplastic drugs | Chemotherapy drug | 1986 |
Advertisement